<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<style>body{background-color:white;}</style>
<link href="Basophils_%28%25%29_files/htmltools-fill-0.5.8.1/fill.css" rel="stylesheet">
<script src="Basophils_%28%25%29_files/htmlwidgets-1.6.4/htmlwidgets.js"></script><script src="Basophils_%28%25%29_files/plotly-binding-4.10.4/plotly.js"></script><script src="Basophils_%28%25%29_files/typedarray-0.1/typedarray.min.js"></script><script src="Basophils_%28%25%29_files/jquery-3.5.1/jquery.min.js"></script><link href="Basophils_%28%25%29_files/crosstalk-1.2.1/css/crosstalk.min.css" rel="stylesheet">
<script src="Basophils_%28%25%29_files/crosstalk-1.2.1/js/crosstalk.min.js"></script><link href="Basophils_%28%25%29_files/plotly-htmlwidgets-css-2.11.1/plotly-htmlwidgets.css" rel="stylesheet">
<script src="Basophils_%28%25%29_files/plotly-main-2.11.1/plotly-latest.min.js"></script><title>Basophils (%)</title>
<link rel="shortcut icon" href="SynDeRxFavicon.png" type="image/x-icon">
</head>
<body>
<div id="htmlwidget_container">
  <div class="plotly html-widget html-fill-item" id="htmlwidget-53ec3ab17c40ebfe512e" style="width:100%;height:400px;"></div>
</div>
<script type="application/json" data-for="htmlwidget-53ec3ab17c40ebfe512e">{"x":{"visdat":{"295c5793b8d":["function () ","plotlyVisDat"]},"cur_data":"295c5793b8d","attrs":{"295c5793b8d":{"connectgaps":true,"mode":"lines+markers","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter"},"295c5793b8d.1":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-8,0,7,14,21,29,42,49,56,64,70,77,92,98,105,113,119,140,147,155,161,168,182,197],"y":[0.59999999999999998,0.80000000000000004,2,2,1.1000000000000001,1,1.2,0.90000000000000002,0.94666666666666677,1,3.2000000000000002,1,0.90000000000000002,2.5,0,0.80000000000000004,0.90000000000000002,0.90000000000000002,1,1,0.80000000000000004,0.80000000000000004,0.80000000000000004,1.5],"name":"CTMS-01","legendgroup":"CTMS-01","hoverinfo":"text","hovertext":["CTMS-1<br>Basophils (%): 0.6 %<br>2022-12-13 5:06<br>Visit: Screening<br>Days Since C1D1: -8","CTMS-1<br>Basophils (%): 0.8 %<br>2022-12-21 9:15<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 0","CTMS-1<br>Basophils (%): 2 %<br>2022-12-28 3:08<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 7","CTMS-1<br>Basophils (%): 2 %<br>2023-01-04 0:18<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 14","CTMS-1<br>Basophils (%): 1.1 %<br>2023-01-11 0:37<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 21","CTMS-1<br>Basophils (%): 1 %<br>2023-01-19 0:41<br>Visit: Cycle 2 Day 8<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 29","CTMS-1<br>Basophils (%): 1.2 %<br>2023-02-01 3:01<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 42","CTMS-1<br>Basophils (%): 0.9 %<br>2023-02-08 1:07<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 49","CTMS-1<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 56","CTMS-1<br>Basophils (%): 1 %<br>2023-02-23 9:35<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 64","CTMS-1<br>Basophils (%): 3.2 %<br>2023-03-01 0:26<br>Visit: Cycle 4 Day 8<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 70","CTMS-1<br>Basophils (%): 1 %<br>2023-03-08 1:04<br>Visit: Cycle 4 Day 15<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 77","CTMS-1<br>Basophils (%): 0.9 %<br>2023-03-23 0:26<br>Visit: Cycle 5 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 92","CTMS-1<br>Basophils (%): 2.5 %<br>2023-03-29 2:47<br>Visit: Cycle 5 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 98","CTMS-1<br>Basophils (%): 0 %<br>2023-04-05 0:50<br>Visit: Cycle 5 Day 15<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 105","CTMS-1<br>Basophils (%): 0.8 %<br>2023-04-13 8:55<br>Visit: Cycle 6 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 113","CTMS-1<br>Basophils (%): 0.9 %<br>2023-04-19 3:04<br>Visit: Cycle 6 Day 8<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 119","CTMS-1<br>Basophils (%): 0.9 %<br>2023-05-10 0:47<br>Visit: Cycle 7 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 140","CTMS-1<br>Basophils (%): 1 %<br>2023-05-17 8:57<br>Visit: Cycle 7 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 147","CTMS-1<br>Basophils (%): 1 %<br>2023-05-25 9:26<br>Visit: Cycle 7 Day 15<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 155","CTMS-1<br>Basophils (%): 0.8 %<br>2023-05-31 9:59<br>Visit: Cycle 8 Day 1<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Days Since C1D1: 161","CTMS-1<br>Basophils (%): 0.8 %<br>2023-06-07 9:33<br>Visit: Cycle 8 Day 8<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 168","CTMS-1<br>Basophils (%): 0.8 %<br>2023-06-21 9:37<br>Visit: Cycle 9 Day 1<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 182","CTMS-1<br>Basophils (%): 1.5 %<br>2023-07-06 9:54<br>Visit: End of Treatment<br>Days Since C1D1: 197"],"textposition":"top right","text":["","Both","Er","Ev","Er","Ev","Both","Er","Ev","Er","Ev","Er","Both","Er","Ev","Er","Ev","Both","Er","Ev","Er","Both","Both",""],"line":{"color":"#2222ff","width":2},"marker":{"symbol":"circle","size":9,"color":"#2222ff"},"inherit":true},"295c5793b8d.2":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-4,0,7,14,21,28,42,49,79,91],"y":[2.8999999999999999,2.9727272727272727,3.1000000000000001,11,1,4,0,3,1.2,1.6000000000000001],"name":"CTMS-02","legendgroup":"CTMS-02","hoverinfo":"text","hovertext":["CTMS-2<br>Basophils (%): 2.9 %<br>2022-10-27 7:54<br>Visit: Screening<br>Days Since C1D1: -4","CTMS-2<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 3 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 0","CTMS-2<br>Basophils (%): 3.1 %<br>2022-11-07 0:21<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 3 mg<br>Days Since C1D1: 7","CTMS-2<br>Basophils (%): 11 %<br>2022-11-14 7:44<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 14","CTMS-2<br>Basophils (%): 1 %<br>2022-11-21 3:30<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 3 mg<br>Days Since C1D1: 21","CTMS-2<br>Basophils (%): 4 %<br>2022-11-28 7:13<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 3 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 28","CTMS-2<br>Basophils (%): 0 %<br>2022-12-12 3:29<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 2.4 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 42","CTMS-2<br>Basophils (%): 3 %<br>2022-12-19 5:47<br>Visit: Cycle 3 Day 8<br>Days Since C1D1: 49","CTMS-2<br>Basophils (%): 1.2 %<br>2023-01-18 9:46<br>Visit: Cycle 5 Day 1<br>Eribulin: 0.7 mg/m2, 1.4 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 79","CTMS-2<br>Basophils (%): 1.6 %<br>2023-01-30 9:04<br>Visit: End of Treatment<br>Days Since C1D1: 91"],"textposition":"top right","text":["","Both","Er","Ev","Er","Both","Both","","Both",""],"line":{"color":"#22cc22","width":2},"marker":{"symbol":"circle","size":9,"color":"#22cc22"},"inherit":true},"295c5793b8d.3":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-8,0,7,14,21,28,42,49,56,63,70,84],"y":[0.29999999999999999,0.20000000000000001,2.3999999999999999,1.3,0.40000000000000002,1,0.29999999999999999,0,1.3999999999999999,0.29999999999999999,0,0.20000000000000001],"name":"CTMS-03","legendgroup":"CTMS-03","hoverinfo":"text","hovertext":["CTMS-3<br>Basophils (%): 0.3 %<br>2023-01-25 2:07<br>Visit: Screening<br>Days Since C1D1: -8","CTMS-3<br>Basophils (%): 0.2 %<br>2023-02-02 2:17<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 0","CTMS-3<br>Basophils (%): 2.4 %<br>2023-02-09 5:19<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Days Since C1D1: 7","CTMS-3<br>Basophils (%): 1.3 %<br>2023-02-16 8:42<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 14","CTMS-3<br>Basophils (%): 0.4 %<br>2023-02-23 8:56<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Days Since C1D1: 21","CTMS-3<br>Basophils (%): 1 %<br>2023-03-02 1:40<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 28","CTMS-3<br>Basophils (%): 0.3 %<br>2023-03-16 9:59<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 42","CTMS-3<br>Basophils (%): 0 %<br>2023-03-23 3:27<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Days Since C1D1: 49","CTMS-3<br>Basophils (%): 1.4 %<br>2023-03-30 3:47<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 56","CTMS-3<br>Basophils (%): 0.3 %<br>2023-04-06 9:37<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Days Since C1D1: 63","CTMS-3<br>Basophils (%): 0 %<br>2023-04-13 1:46<br>Visit: Cycle 4 Day 8<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 70","CTMS-3<br>Basophils (%): 0.2 %<br>2023-04-27 9:55<br>Visit: End of Treatment<br>Days Since C1D1: 84"],"textposition":"top right","text":["","Both","Er","Ev","Er","Both","Both","Er","Ev","Er","Both",""],"line":{"color":"black","width":2},"marker":{"symbol":"circle","size":9,"color":"black"},"inherit":true},"295c5793b8d.4":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-1,0,7,26],"y":[0.5,0.40000000000000002,2,0.59999999999999998],"name":"CTMS-04","legendgroup":"CTMS-04","hoverinfo":"text","hovertext":["CTMS-4<br>Basophils (%): 0.5 %<br>2023-03-01 9:16<br>Visit: Screening<br>Days Since C1D1: -1","CTMS-4<br>Basophils (%): 0.4 %<br>2023-03-02 1:58<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.3 mg<br>Evexomostat: 49 mg/m2, 80 mg<br>Days Since C1D1: 0","CTMS-4<br>Basophils (%): 2 %<br>2023-03-09 2:52<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 7","CTMS-4<br>Basophils (%): 0.6 %<br>2023-03-28 2:44<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 80 mg<br>Days Since C1D1: 26"],"textposition":"top right","text":["","Both","","Ev"],"line":{"color":"#ff7777","width":2},"marker":{"symbol":"circle","size":9,"color":"#ff7777"},"inherit":true},"295c5793b8d.5":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-8,0,7,14,21,29,43,50,64,71,78,85,106],"y":[1,0.69999999999999996,1,1,1.3,0.90000000000000002,0.80000000000000004,0.29999999999999999,0.5,0.69999999999999996,0.90000000000000002,1,0.40000000000000002],"name":"CTMS-05","legendgroup":"CTMS-05","hoverinfo":"text","hovertext":["CTMS-5<br>Basophils (%): 1 %<br>2023-03-21 9:53<br>Visit: Screening<br>Days Since C1D1: -8","CTMS-5<br>Basophils (%): 0.7 %<br>2023-03-29 8:55<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.9 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 0","CTMS-5<br>Basophils (%): 1 %<br>2023-04-05 0:35<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.9 mg<br>Days Since C1D1: 7","CTMS-5<br>Basophils (%): 1 %<br>2023-04-12 2:16<br>Visit: Cycle 1 Day 15<br>Days Since C1D1: 14","CTMS-5<br>Basophils (%): 1.3 %<br>2023-04-19 8:43<br>Visit: Cycle 2 Day 1<br>Days Since C1D1: 21","CTMS-5<br>Basophils (%): 0.9 %<br>2023-04-27 9:38<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 29","CTMS-5<br>Basophils (%): 0.8 %<br>2023-05-11 9:25<br>Visit: Cycle 3 Day 1<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 43","CTMS-5<br>Basophils (%): 0.3 %<br>2023-05-18 8:22<br>Visit: Cycle 3 Day 8<br>Days Since C1D1: 50","CTMS-5<br>Basophils (%): 0.5 %<br>2023-06-01 2:18<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 75 mg<br>Days Since C1D1: 64","CTMS-5<br>Basophils (%): 0.7 %<br>2023-06-08 8:42<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.1 mg/m2, 2.3 mg<br>Days Since C1D1: 71","CTMS-5<br>Basophils (%): 0.9 %<br>2023-06-15 8:24<br>Visit: Cycle 4 Day 8<br>Days Since C1D1: 78","CTMS-5<br>Basophils (%): 1 %<br>2023-06-22 8:35<br>Visit: Cycle 4 Day 15<br>Evexomostat: 49 mg/m2, 75 mg<br>Days Since C1D1: 85","CTMS-5<br>Basophils (%): 0.4 %<br>2023-07-13 9:43<br>Visit: End of Treatment<br>Days Since C1D1: 106"],"textposition":"top right","text":["","Both","Er","","","","Ev","","Ev","Er","","Ev",""],"line":{"color":"#ff00ff","width":2},"marker":{"symbol":"circle","size":9,"color":"#ff00ff"},"inherit":true},"295c5793b8d.6":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-17,0,7,18,26,35,78],"y":[0.29999999999999999,0.40000000000000002,0.59999999999999998,0.29999999999999999,0.40000000000000002,0.20000000000000001,0.29999999999999999],"name":"CTMS-06","legendgroup":"CTMS-06","hoverinfo":"text","hovertext":["CTMS-6<br>Basophils (%): 0.3 %<br>2023-06-19 0:54<br>Visit: Screening<br>Days Since C1D1: -17","CTMS-6<br>Basophils (%): 0.4 %<br>2023-07-06 2:36<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 3.4 mg<br>Evexomostat: 49 mg/m2, 120 mg<br>Days Since C1D1: 0","CTMS-6<br>Basophils (%): 0.6 %<br>2023-07-13 9:41<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 3.4 mg<br>Days Since C1D1: 7","CTMS-6<br>Basophils (%): 0.3 %<br>2023-07-24 9:24<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 120 mg<br>Days Since C1D1: 18","CTMS-6<br>Basophils (%): 0.4 %<br>2023-08-01 0:54<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 2.6 mg<br>Days Since C1D1: 26","CTMS-6<br>Basophils (%): 0.2 %<br>2023-08-10 2:03<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 2.6 mg<br>Evexomostat: 49 mg/m2, 120 mg<br>Days Since C1D1: 35","CTMS-6<br>Basophils (%): 0.3 %<br>2023-09-22 8:56<br>Visit: End of Treatment<br>Days Since C1D1: 78"],"textposition":"top right","text":["","Both","Er","Ev","Er","Both",""],"line":{"color":"orange","width":2},"marker":{"symbol":"circle","size":9,"color":"orange"},"inherit":true},"295c5793b8d.7":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-5,0,7,16,28,35,49,56,65,70,77,98,105,112,119,126,140,147,154,161,168,185,189,199,203,210,224,231,238,245,252,266,273,280,287,295,308,315,322,336,343,350,357,364,378,385,392,399,406,420,428,434,441,448,462,469,476,483,490,504,511,520,525,533,546],"y":[0.5,0.59999999999999998,1,0,1.7,0,1,3.2000000000000002,0,1.5,0.80000000000000004,0.80000000000000004,0.59999999999999998,0.90000000000000002,0.69999999999999996,0.69999999999999996,0.69999999999999996,1,0.59999999999999998,0.40000000000000002,0.69999999999999996,0.69999999999999996,1,0.59999999999999998,1.1000000000000001,0.29999999999999999,0.59999999999999998,0.69999999999999996,0.20000000000000001,0.5,0.29999999999999999,0.59999999999999998,0.29999999999999999,0.59999999999999998,0.29999999999999999,0.40000000000000002,0.80000000000000004,0.59999999999999998,0.59999999999999998,0.69999999999999996,0.80000000000000004,1,0.5,0.69999999999999996,0.69999999999999996,1,0.80000000000000004,0,0.59999999999999998,0.5,0.29999999999999999,0,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.5,0.69999999999999996,0.40000000000000002,0.40000000000000002],"name":"CTMS-07","legendgroup":"CTMS-07","hoverinfo":"text","hovertext":["CTMS-7<br>Basophils (%): 0.5 %<br>2023-06-28 9:48<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-7<br>Basophils (%): 0.6 %<br>2023-07-03 2:08<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.3 mg<br>Evexomostat: 49 mg/m2, 80 mg<br>Days Since C1D1: 0","CTMS-7<br>Basophils (%): 1 %<br>2023-07-10 4:05<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.3 mg<br>Days Since C1D1: 7","CTMS-7<br>Basophils (%): 0 %<br>2023-07-19 4:32<br>Visit: Cycle 1 Day 15<br>Days Since C1D1: 16","CTMS-7<br>Basophils (%): 1.7 %<br>2023-07-31 1:51<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 28","CTMS-7<br>Basophils (%): 0 %<br>2023-08-07 1:05<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 35","CTMS-7<br>Basophils (%): 1 %<br>2023-08-21 9:54<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 49","CTMS-7<br>Basophils (%): 3.2 %<br>2023-08-28 0:56<br>Visit: Cycle 3 Day 8<br>Days Since C1D1: 56","CTMS-7<br>Basophils (%): 0 %<br>2023-09-06 9:36<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 65","CTMS-7<br>Basophils (%): 1.5 %<br>2023-09-11 0:22<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.4 mg/m2, 1.1 mg<br>Days Since C1D1: 70","CTMS-7<br>Basophils (%): 0.8 %<br>2023-09-18 5:44<br>Visit: Cycle 4 Day 8<br>Eribulin: 1.4 mg/m2, 1.1 mg<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 77","CTMS-7<br>Basophils (%): 0.8 %<br>2023-10-09 9:36<br>Visit: Cycle 5 Day 1<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 98","CTMS-7<br>Basophils (%): 0.6 %<br>2023-10-16 9:47<br>Visit: Cycle 5 Day 8<br>Days Since C1D1: 105","CTMS-7<br>Basophils (%): 0.9 %<br>2023-10-23 8:46<br>Visit: Cycle 5 Day 15<br>Days Since C1D1: 112","CTMS-7<br>Basophils (%): 0.7 %<br>2023-10-30 9:57<br>Visit: Cycle 6 Day 1<br>Days Since C1D1: 119","CTMS-7<br>Basophils (%): 0.7 %<br>2023-11-06 8:45<br>Visit: Cycle 6 Day 8<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 126","CTMS-7<br>Basophils (%): 0.7 %<br>2023-11-20 8:38<br>Visit: Cycle 7 Day 1<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 140","CTMS-7<br>Basophils (%): 1 %<br>2023-11-27 5:28<br>Visit: Cycle 7 Day 8<br>Days Since C1D1: 147","CTMS-7<br>Basophils (%): 0.6 %<br>2023-12-04 5:29<br>Visit: Cycle 7 Day 15<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 154","CTMS-7<br>Basophils (%): 0.4 %<br>2023-12-11 8:53<br>Visit: Cycle 8 Day 1<br>Days Since C1D1: 161","CTMS-7<br>Basophils (%): 0.7 %<br>2023-12-18 0:20<br>Visit: Cycle 8 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 168","CTMS-7<br>Basophils (%): 0.7 %<br>2024-01-04 1:10<br>Visit: Cycle 9 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 185","CTMS-7<br>Basophils (%): 1 %<br>2024-01-08 5:43<br>Visit: Cycle 9 Day 8<br>Days Since C1D1: 189","CTMS-7<br>Basophils (%): 0.6 %<br>2024-01-18 0:07<br>Visit: Cycle 9 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 199","CTMS-7<br>Basophils (%): 1.1 %<br>2024-01-22 5:46<br>Visit: Cycle 10 Day 1<br>Days Since C1D1: 203","CTMS-7<br>Basophils (%): 0.3 %<br>2024-01-29 4:41<br>Visit: Cycle 1 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 210","CTMS-7<br>Basophils (%): 0.6 %<br>2024-02-12 5:02<br>Visit: Cycle 11 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 224","CTMS-7<br>Basophils (%): 0.7 %<br>2024-02-19 4:36<br>Visit: Cycle 11 Day 8<br>Days Since C1D1: 231","CTMS-7<br>Basophils (%): 0.2 %<br>2024-02-26 9:11<br>Visit: Cycle 11 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 238","CTMS-7<br>Basophils (%): 0.5 %<br>2024-03-04 9:16<br>Visit: Cycle 12 Day 1<br>Days Since C1D1: 245","CTMS-7<br>Basophils (%): 0.3 %<br>2024-03-11 8:28<br>Visit: Cycle 12 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 252","CTMS-7<br>Basophils (%): 0.6 %<br>2024-03-25 8:57<br>Visit: Cycle 13 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 266","CTMS-7<br>Basophils (%): 0.3 %<br>2024-04-01 9:55<br>Visit: Cycle 13 Day 8<br>Days Since C1D1: 273","CTMS-7<br>Basophils (%): 0.6 %<br>2024-04-08 9:30<br>Visit: Cycle 13 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 280","CTMS-7<br>Basophils (%): 0.3 %<br>2024-04-15 3:12<br>Visit: Cycle 14 Day 1<br>Days Since C1D1: 287","CTMS-7<br>Basophils (%): 0.4 %<br>2024-04-23 8:13<br>Visit: Cycle 14 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 295","CTMS-7<br>Basophils (%): 0.8 %<br>2024-05-06 9:25<br>Visit: Cycle 15 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 308","CTMS-7<br>Basophils (%): 0.6 %<br>2024-05-13 9:54<br>Visit: Cycle 15 Day 8<br>Days Since C1D1: 315","CTMS-7<br>Basophils (%): 0.6 %<br>2024-05-20 0:45<br>Visit: Cycle 15 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 322","CTMS-7<br>Basophils (%): 0.7 %<br>2024-06-03 0:34<br>Visit: Cycle 16 Day 1<br>Eribulin: 0.7 mg/m2, 1.1 mg<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 336","CTMS-7<br>Basophils (%): 0.8 %<br>2024-06-10 8:52<br>Visit: Cycle 16 Day 8<br>Eribulin: 0.7 mg/m2, 1.1 mg<br>Days Since C1D1: 343","CTMS-7<br>Basophils (%): 1 %<br>2024-06-17 9:17<br>Visit: Cycle 16 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 350","CTMS-7<br>Basophils (%): 0.5 %<br>2024-06-24 0:21<br>Visit: Cycle 17 Day 1<br>Eribulin: 0.7 mg/m2, 1.1 mg<br>Days Since C1D1: 357","CTMS-7<br>Basophils (%): 0.7 %<br>2024-07-01 9:17<br>Visit: Cycle 17 Day 8<br>Days Since C1D1: 364","CTMS-7<br>Basophils (%): 0.7 %<br>2024-07-15 1:58<br>Visit: Cycle 18 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 378","CTMS-7<br>Basophils (%): 1 %<br>2024-07-22 9:42<br>Visit: Cycle 18 Day 8<br>Days Since C1D1: 385","CTMS-7<br>Basophils (%): 0.8 %<br>2024-07-29 9:32<br>Visit: Cycle 18 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 392","CTMS-7<br>Basophils (%): 0 %<br>2024-08-05 9:35<br>Visit: Cycle 19 Day 1<br>Days Since C1D1: 399","CTMS-7<br>Basophils (%): 0.6 %<br>2024-08-12 9:28<br>Visit: Cycle 19 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 406","CTMS-7<br>Basophils (%): 0.5 %<br>2024-08-26 9:12<br>Visit: Cycle 20 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 420","CTMS-7<br>Basophils (%): 0.3 %<br>2024-09-03 8:21<br>Visit: Cycle 20 Day 8<br>Days Since C1D1: 428","CTMS-7<br>Basophils (%): 0 %<br>2024-09-09 9:24<br>Visit: Cycle 20 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 434","CTMS-7<br>Basophils (%): 0.4 %<br>2024-09-16 8:21<br>Visit: Cycle 21 Day 1<br>Days Since C1D1: 441","CTMS-7<br>Basophils (%): 0.4 %<br>2024-09-23 1:02<br>Visit: Cycle 21 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 448","CTMS-7<br>Basophils (%): 0.4 %<br>2024-10-07 9:34<br>Visit: Cycle 22 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 462","CTMS-7<br>Basophils (%): 0.4 %<br>2024-10-14 1:41<br>Visit: Cycle 22 Day 8<br>Days Since C1D1: 469","CTMS-7<br>Basophils (%): 0.4 %<br>2024-10-21 8:48<br>Visit: Cycle 22 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 476","CTMS-7<br>Basophils (%): 0.4 %<br>2024-10-28 8:28<br>Visit: Cycle 23 Day 1<br>Days Since C1D1: 483","CTMS-7<br>Basophils (%): 0.4 %<br>2024-11-04 9:03<br>Visit: Cycle 23 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 490","CTMS-7<br>Basophils (%): 0.4 %<br>2024-11-18 0:16<br>Visit: Cycle 24 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 504","CTMS-7<br>Basophils (%): 0.4 %<br>2024-11-25 9:24<br>Visit: NA<br>Days Since C1D1: 511","CTMS-7<br>Basophils (%): 0.5 %<br>2024-12-04 5:25<br>Visit: Cycle 24 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 520","CTMS-7<br>Basophils (%): 0.7 %<br>2024-12-09 0:12<br>Visit: NA<br>Days Since C1D1: 525","CTMS-7<br>Basophils (%): 0.4 %<br>2024-12-17 4:27<br>Visit: Cycle 25 Day 8<br>Evexomostat: 49 mg/m2, 50 mg<br>Days Since C1D1: 533","CTMS-7<br>Basophils (%): 0.4 %<br>2024-12-30 9:07<br>Visit: End of Treatment<br>Days Since C1D1: 546"],"textposition":"top right","text":["","Both","Er","","Both","Er","Both","","Ev","Er","Both","Ev","","","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","Both","Er","Ev","Er","","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev",""],"line":{"color":"#2222ff","width":2},"marker":{"symbol":"square","size":9,"color":"#2222ff"},"inherit":true},"295c5793b8d.8":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-3,0,7,14,22,29,42,50,57,64,70,85],"y":[0.5,0.29999999999999999,2,0,0.5,1.3999999999999999,0.5,2.7999999999999998,1,0,0,0.80000000000000004],"name":"CTMS-08","legendgroup":"CTMS-08","hoverinfo":"text","hovertext":["CTMS-8<br>Basophils (%): 0.5 %<br>2023-07-03 2:21<br>Visit: Screening<br>Days Since C1D1: -3","CTMS-8<br>Basophils (%): 0.3 %<br>2023-07-06 4:41<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 0","CTMS-8<br>Basophils (%): 2 %<br>2023-07-13 2:57<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 7","CTMS-8<br>Basophils (%): 0 %<br>2023-07-20 9:10<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 14","CTMS-8<br>Basophils (%): 0.5 %<br>2023-07-28 8:25<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 22","CTMS-8<br>Basophils (%): 1.4 %<br>2023-08-04 8:43<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 29","CTMS-8<br>Basophils (%): 0.5 %<br>2023-08-17 3:53<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 2.2 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 42","CTMS-8<br>Basophils (%): 2.8 %<br>2023-08-25 0:09<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 2.2 mg<br>Days Since C1D1: 50","CTMS-8<br>Basophils (%): 1 %<br>2023-09-01 1:27<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 57","CTMS-8<br>Basophils (%): 0 %<br>2023-09-08 0:36<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.1 mg/m2, 2.2 mg<br>Days Since C1D1: 64","CTMS-8<br>Basophils (%): 0 %<br>2023-09-14 4:52<br>Visit: Cycle 4 Day 8<br>Days Since C1D1: 70","CTMS-8<br>Basophils (%): 0.8 %<br>2023-09-29 9:00<br>Visit: End of Treatment<br>Days Since C1D1: 85"],"textposition":"top right","text":["","Both","Er","Ev","Er","","Both","Er","Ev","Er","",""],"line":{"color":"#22cc22","width":2},"marker":{"symbol":"square","size":9,"color":"#22cc22"},"inherit":true},"295c5793b8d.9":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-7,0,7],"y":[0.20000000000000001,0.40000000000000002,2.2999999999999998],"name":"CTMS-09","legendgroup":"CTMS-09","hoverinfo":"text","hovertext":["CTMS-9<br>Basophils (%): 0.2 %<br>2023-07-03 2:17<br>Visit: Screening<br>Days Since C1D1: -7","CTMS-9<br>Basophils (%): 0.4 %<br>2023-07-10 0:28<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 0","CTMS-9<br>Basophils (%): 2.3 %<br>2023-07-17 1:47<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 7"],"textposition":"top right","text":["","Both","Er"],"line":{"color":"black","width":2},"marker":{"symbol":"square","size":9,"color":"black"},"inherit":true},"295c5793b8d.10":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-5,0,7,14],"y":[0.29999999999999999,0.40000000000000002,1,0.90000000000000002],"name":"CTMS-10","legendgroup":"CTMS-10","hoverinfo":"text","hovertext":["CTMS-10<br>Basophils (%): 0.3 %<br>2023-11-10 0:39<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-10<br>Basophils (%): 0.4 %<br>2023-11-15 1:07<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 3.1 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 0","CTMS-10<br>Basophils (%): 1 %<br>2023-11-22 1:06<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 3.1 mg<br>Days Since C1D1: 7","CTMS-10<br>Basophils (%): 0.9 %<br>2023-11-29 9:46<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 14"],"textposition":"top right","text":["","Both","Er","Ev"],"line":{"color":"#ff7777","width":2},"marker":{"symbol":"square","size":9,"color":"#ff7777"},"inherit":true},"295c5793b8d.11":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-1,0,7,14,20,27,41,48,55,69,71,78,83,90,97,111,117,139,146,153,161],"y":[0.40000000000000002,0.5,1.8,0.93846153846153868,0.20000000000000001,2.7999999999999998,0.29999999999999999,0.29999999999999999,1.3,0.5,0.54444444444444429,0.69999999999999996,1,0.20000000000000001,0.59999999999999998,0.40000000000000002,0.5,0.80000000000000004,0.59999999999999998,1,0.20000000000000001],"name":"CTMS-11","legendgroup":"CTMS-11","hoverinfo":"text","hovertext":["CTMS-11<br>Basophils (%): 0.4 %<br>2024-01-16 8:25<br>Visit: Screening<br>Days Since C1D1: -1","CTMS-11<br>Basophils (%): 0.5 %<br>2024-01-17 9:00<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 0","CTMS-11<br>Basophils (%): 1.8 %<br>2024-01-24 0:12<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Days Since C1D1: 7","CTMS-11<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 14","CTMS-11<br>Basophils (%): 0.2 %<br>2024-02-06 9:13<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Days Since C1D1: 20","CTMS-11<br>Basophils (%): 2.8 %<br>2024-02-13 0:40<br>Visit: Cycle 2 Day 8<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 27","CTMS-11<br>Basophils (%): 0.3 %<br>2024-02-27 8:35<br>Visit: Cycle 3 Day 1<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 41","CTMS-11<br>Basophils (%): 0.3 %<br>2024-03-05 8:35<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Days Since C1D1: 48","CTMS-11<br>Basophils (%): 1.3 %<br>2024-03-12 8:24<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 55","CTMS-11<br>Basophils (%): 0.5 %<br>2024-03-26 0:43<br>Visit: Cycle 4 Day 1<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 69","CTMS-11<br>Visit: Cycle 4 Day 1<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 71","CTMS-11<br>Basophils (%): 0.7 %<br>2024-04-04 7:58<br>Visit: Cycle 4 Day 8<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 78","CTMS-11<br>Basophils (%): 1 %<br>2024-04-09 6:37<br>Visit: Cycle 4 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 83","CTMS-11<br>Basophils (%): 0.2 %<br>2024-04-16 1:17<br>Visit: Cycle 5 Day 1<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 90","CTMS-11<br>Basophils (%): 0.6 %<br>2024-04-23 8:27<br>Visit: Cycle 5 Day 8<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 97","CTMS-11<br>Basophils (%): 0.4 %<br>2024-05-07 0:51<br>Visit: Cycle 6 Day 1<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 111","CTMS-11<br>Basophils (%): 0.5 %<br>2024-05-13 7:51<br>Visit: Cycle 6 Day 8<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 117","CTMS-11<br>Basophils (%): 0.8 %<br>2024-06-04 1:40<br>Visit: Cycle 7 Day 1<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 139","CTMS-11<br>Basophils (%): 0.6 %<br>2024-06-11 1:30<br>Visit: Cycle 7 Day 8<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 146","CTMS-11<br>Basophils (%): 1 %<br>2024-06-18 2:22<br>Visit: Cycle 7 Day 15<br>Evexomostat: 49 mg/m2, 80 mg<br>Days Since C1D1: 153","CTMS-11<br>Basophils (%): 0.2 %<br>2024-06-26 0:31<br>Visit: End of Treatment<br>Days Since C1D1: 161"],"textposition":"top right","text":["","Both","Er","Ev","Er","Ev","Ev","Er","Ev","Ev","Er","Er","Ev","Er","Both","Both","Er","Ev","Er","Ev",""],"line":{"color":"#ff00ff","width":2},"marker":{"symbol":"square","size":9,"color":"#ff00ff"},"inherit":true},"295c5793b8d.12":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-5,0,13,20,26,27,34,47,48,54,55,61,62,69,76,89,90,97,99,104,110,111,118,132,139,146,153,160,174,181,188,195,202,216,223,230,245],"y":[0.29999999999999999,0.80000000000000004,0.10000000000000001,0.26153846153846161,0.40000000000000002,0.58750000000000036,1.8999999999999999,2.7000000000000002,2.7999999999999998,3.3999999999999999,2.914285714285711,0,0.049999999999999822,0.40000000000000002,2.6000000000000001,2.6000000000000001,2.5875000000000004,2.5,1.928571428571427,0.5,1,1.125,2,1.5,2.2000000000000002,4,0.69999999999999996,2.3999999999999999,0.90000000000000002,1,1.8999999999999999,0.59999999999999998,2.3999999999999999,1,2.2000000000000002,3,1.8999999999999999],"name":"CTMS-12","legendgroup":"CTMS-12","hoverinfo":"text","hovertext":["CTMS-12<br>Basophils (%): 0.3 %<br>2024-01-12 2:35<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-12<br>Basophils (%): 0.8 %<br>2024-01-17 0:49<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 0","CTMS-12<br>Basophils (%): 0.1 %<br>2024-01-30 4:03<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 13","CTMS-12<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 20","CTMS-12<br>Basophils (%): 0.4 %<br>2024-02-12 6:34<br>Visit: Cycle 2 Day 1<br>Days Since C1D1: 26","CTMS-12<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Days Since C1D1: 27","CTMS-12<br>Basophils (%): 1.9 %<br>2024-02-20 0:43<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 34","CTMS-12<br>Basophils (%): 2.7 %<br>2024-03-04 6:30<br>Visit: Cycle 3 Day 1<br>Days Since C1D1: 47","CTMS-12<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 48","CTMS-12<br>Basophils (%): 3.4 %<br>2024-03-11 6:26<br>Visit: Cycle 3 Day 8<br>Days Since C1D1: 54","CTMS-12<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Days Since C1D1: 55","CTMS-12<br>Basophils (%): 0 %<br>2024-03-18 6:12<br>Visit: Cycle 3 Day 15<br>Days Since C1D1: 61","CTMS-12<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 62","CTMS-12<br>Basophils (%): 0.4 %<br>2024-03-26 0:29<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 69","CTMS-12<br>Basophils (%): 2.6 %<br>2024-04-02 0:37<br>Visit: Cycle 4 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 76","CTMS-12<br>Basophils (%): 2.6 %<br>2024-04-15 6:00<br>Visit: NA<br>Days Since C1D1: 89","CTMS-12<br>Visit: Cycle 5 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 90","CTMS-12<br>Basophils (%): 2.5 %<br>2024-04-23 0:01<br>Visit: Cycle 5 Day 8<br>Days Since C1D1: 97","CTMS-12<br>Visit: Cycle 5 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 99","CTMS-12<br>Basophils (%): 0.5 %<br>2024-04-30 9:44<br>Visit: Cycle 5 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 104","CTMS-12<br>Basophils (%): 1 %<br>2024-05-06 6:40<br>Visit: NA<br>Days Since C1D1: 110","CTMS-12<br>Visit: Cycle 6 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 111","CTMS-12<br>Basophils (%): 2 %<br>2024-05-14 0:37<br>Visit: Cycle 6 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 118","CTMS-12<br>Basophils (%): 1.5 %<br>2024-05-28 1:31<br>Visit: Cycle 7 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 132","CTMS-12<br>Basophils (%): 2.2 %<br>2024-06-04 0:02<br>Visit: Cycle 7 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 139","CTMS-12<br>Basophils (%): 4 %<br>2024-06-11 0:22<br>Visit: Cycle 7 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 146","CTMS-12<br>Basophils (%): 0.7 %<br>2024-06-18 9:05<br>Visit: Cycle 8 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 153","CTMS-12<br>Basophils (%): 2.4 %<br>2024-06-25 9:38<br>Visit: Cycle 8 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 160","CTMS-12<br>Basophils (%): 0.9 %<br>2024-07-09 9:23<br>Visit: Cycle 9 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 174","CTMS-12<br>Basophils (%): 1 %<br>2024-07-16 9:53<br>Visit: Cycle 9 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 181","CTMS-12<br>Basophils (%): 1.9 %<br>2024-07-23 0:18<br>Visit: Cycle 9 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 188","CTMS-12<br>Basophils (%): 0.6 %<br>2024-07-30 0:59<br>Visit: Cycle 10 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 195","CTMS-12<br>Basophils (%): 2.4 %<br>2024-08-06 9:50<br>Visit: Cycle 10 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 202","CTMS-12<br>Basophils (%): 1 %<br>2024-08-20 0:39<br>Visit: Cycle 11 Day 1<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 216","CTMS-12<br>Basophils (%): 2.2 %<br>2024-08-27 8:54<br>Visit: Cycle 11 Day 8<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Days Since C1D1: 223","CTMS-12<br>Basophils (%): 3 %<br>2024-09-03 9:27<br>Visit: Cycle 11 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 230","CTMS-12<br>Basophils (%): 1.9 %<br>2024-09-18 9:12<br>Visit: End of Treatment<br>Days Since C1D1: 245"],"textposition":"top right","text":["","Both","Er","Ev","","Er","Both","","Both","","Er","","Ev","Er","Both","","Both","","Er","Ev","","Er","Both","Both","Er","Ev","Er","Both","Both","Er","Ev","Er","Both","Both","Er","Ev",""],"line":{"color":"orange","width":2},"marker":{"symbol":"square","size":9,"color":"orange"},"inherit":true},"295c5793b8d.13":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-7,0,8,14,21,27,28,42,49,56,63,70,84],"y":[0.59999999999999998,0.40000000000000002,2.1000000000000001,1,0.90000000000000002,0.5,0.50666666666666671,0.59999999999999998,0.5,0.10000000000000001,0.29999999999999999,0.39999999999999991,0.59999999999999998],"name":"CTMS-13","legendgroup":"CTMS-13","hoverinfo":"text","hovertext":["CTMS-13<br>Basophils (%): 0.6 %<br>2024-01-17 9:44<br>Visit: Screening<br>Days Since C1D1: -7","CTMS-13<br>Basophils (%): 0.4 %<br>2024-01-24 8:50<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 0","CTMS-13<br>Basophils (%): 2.1 %<br>2024-02-01 4:50<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Days Since C1D1: 8","CTMS-13<br>Basophils (%): 1 %<br>2024-02-07 2:40<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 14","CTMS-13<br>Basophils (%): 0.9 %<br>2024-02-14 2:40<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Days Since C1D1: 21","CTMS-13<br>Basophils (%): 0.5 %<br>2024-02-20 9:17<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 27","CTMS-13<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 28","CTMS-13<br>Basophils (%): 0.6 %<br>2024-03-06 9:18<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 42","CTMS-13<br>Basophils (%): 0.5 %<br>2024-03-13 0:35<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Days Since C1D1: 49","CTMS-13<br>Basophils (%): 0.1 %<br>2024-03-20 1:00<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 56","CTMS-13<br>Basophils (%): 0.3 %<br>2024-03-27 9:03<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Days Since C1D1: 63","CTMS-13<br>Visit: Cycle 4 Day 8<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 70","CTMS-13<br>Basophils (%): 0.6 %<br>2024-04-17 9:20<br>Visit: End of Treatment<br>Days Since C1D1: 84"],"textposition":"top right","text":["","Both","Er","Ev","Er","","Both","Both","Er","Ev","Er","Both",""],"line":{"color":"#2222ff","width":2},"marker":{"symbol":"diamond","size":9,"color":"#2222ff"},"inherit":true},"295c5793b8d.14":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-20,0,6,14,21,27,27],"y":[1,1,0.40000000000000002,1,1.1000000000000001,1.1000000000000001,1.1000000000000001],"name":"CTMS-14","legendgroup":"CTMS-14","hoverinfo":"text","hovertext":["CTMS-14<br>Basophils (%): 1 <br>2024-02-01 0:15<br>Visit: Screening<br>Days Since C1D1: -20","CTMS-14<br>Basophils (%): 1 <br>2024-02-21 9:43<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.1 mg<br>Evexomostat: 49 mg/m2, 74 mg<br>Days Since C1D1: 0","CTMS-14<br>Basophils (%): 0.4 %<br>2024-02-27 9:31<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 6","CTMS-14<br>Basophils (%): 1 %<br>2024-03-06 9:57<br>Visit: Cycle 1 Day 15<br>Days Since C1D1: 14","CTMS-14<br>Basophils (%): 1.1 %<br>2024-03-13 9:22<br>Visit: Cycle 2 Day 1<br>Days Since C1D1: 21","CTMS-14<br>Basophils (%): 1.1 %<br>2024-03-19 9:34<br>Visit: End of Treatment<br>Days Since C1D1: 27","CTMS-14<br>Basophils (%): 1.1 %<br>2024-03-19 9:34<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 27"],"textposition":"top right","text":["","Both","","","","",""],"line":{"color":"#22cc22","width":2},"marker":{"symbol":"diamond","size":9,"color":"#22cc22"},"inherit":true},"295c5793b8d.15":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-5,0,7],"y":[0.40000000000000002,0.5,0.80000000000000004],"name":"CTMS-15","legendgroup":"CTMS-15","hoverinfo":"text","hovertext":["CTMS-15<br>Basophils (%): 0.4 %<br>2024-03-29 9:11<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-15<br>Basophils (%): 0.5 %<br>2024-04-03 1:24<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 0","CTMS-15<br>Basophils (%): 0.8 %<br>2024-04-10 4:32<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Days Since C1D1: 7"],"textposition":"top right","text":["","Both","Er"],"line":{"color":"black","width":2},"marker":{"symbol":"diamond","size":9,"color":"black"},"inherit":true},"295c5793b8d.16":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-14,0,7,14,21,28,49,56,70],"y":[0.40000000000000002,0.20000000000000001,0,0,0.40000000000000002,0.69999999999999996,0.10000000000000001,0.40000000000000002,0.10000000000000001],"name":"CTMS-16","legendgroup":"CTMS-16","hoverinfo":"text","hovertext":["CTMS-16<br>Basophils (%): 0.4 %<br>2024-03-28 2:42<br>Visit: Screening<br>Days Since C1D1: -14","CTMS-16<br>Basophils (%): 0.2 %<br>2024-04-11 2:05<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 0","CTMS-16<br>Basophils (%): 0 %<br>2024-04-18 0:04<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 7","CTMS-16<br>Basophils (%): 0 %<br>2024-04-25 4:41<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 14","CTMS-16<br>Basophils (%): 0.4 %<br>2024-05-02 2:50<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 21","CTMS-16<br>Basophils (%): 0.7 %<br>2024-05-09 9:52<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 28","CTMS-16<br>Basophils (%): 0.1 %<br>2024-05-30 0:24<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 49","CTMS-16<br>Basophils (%): 0.4 %<br>2024-06-06 4:29<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 56","CTMS-16<br>Basophils (%): 0.1 %<br>2024-06-20 8:45<br>Visit: End of Treatment<br>Days Since C1D1: 70"],"textposition":"top right","text":["","Both","Er","Ev","Er","Both","Er","Er",""],"line":{"color":"#ff7777","width":2},"marker":{"symbol":"diamond","size":9,"color":"#ff7777"},"inherit":true},"295c5793b8d.17":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-5,0,6,14,16,22,28,42,49,56],"y":[0.59999999999999998,0.59999999999999998,1,0.5,0.47499999999999998,0.40000000000000002,0.40000000000000002,0.29999999999999999,0.20000000000000001,2],"name":"CTMS-17","legendgroup":"CTMS-17","hoverinfo":"text","hovertext":["CTMS-17<br>Basophils (%): 0.6 %<br>2024-05-31 9:33<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-17<br>Basophils (%): 0.6 %<br>2024-06-05 9:56<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.66 mg<br>Evexomostat: 49 mg/m2, 93 mg<br>Days Since C1D1: 0","CTMS-17<br>Basophils (%): 1 %<br>2024-06-11 8:43<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 6","CTMS-17<br>Basophils (%): 0.5 %<br>2024-06-19 9:26<br>Visit: Cycle 1 Day 15<br>Days Since C1D1: 14","CTMS-17<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 93 mg<br>Days Since C1D1: 16","CTMS-17<br>Basophils (%): 0.4 %<br>2024-06-27 9:31<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 2.09 mg<br>Days Since C1D1: 22","CTMS-17<br>Basophils (%): 0.4 %<br>2024-07-03 8:58<br>Visit: Cycle 2 Day 8<br>Evexomostat: 49 mg/m2, 93 mg<br>Days Since C1D1: 28","CTMS-17<br>Basophils (%): 0.3 %<br>2024-07-17 9:06<br>Visit: Cycle 3 Day 1<br>Evexomostat: 49 mg/m2, 93 mg<br>Days Since C1D1: 42","CTMS-17<br>Basophils (%): 0.2 %<br>2024-07-24 9:22<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 1.3 mg<br>Days Since C1D1: 49","CTMS-17<br>Basophils (%): 2 %<br>2024-07-31 9:42<br>Visit: End of Treatment<br>Days Since C1D1: 56"],"textposition":"top right","text":["","Both","","","Ev","Er","Ev","Ev","Er",""],"line":{"color":"#ff00ff","width":2},"marker":{"symbol":"diamond","size":9,"color":"#ff00ff"},"inherit":true},"295c5793b8d.18":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-5,0,7,14,22,28,43,49,56,76],"y":[0.59999999999999998,0.5,3.2000000000000002,0.69999999999999996,0.59999999999999998,1.8,0.59999999999999998,1.3,1.8,0.59999999999999998],"name":"CTMS-18","legendgroup":"CTMS-18","hoverinfo":"text","hovertext":["CTMS-18<br>Basophils (%): 0.6 %<br>2024-06-14 9:43<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-18<br>Basophils (%): 0.5 %<br>2024-06-19 0:34<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.18 mg<br>Evexomostat: 49 mg/m2, 78 mg<br>Days Since C1D1: 0","CTMS-18<br>Basophils (%): 3.2 %<br>2024-06-26 9:28<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 7","CTMS-18<br>Basophils (%): 0.7 %<br>2024-07-03 9:40<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 78 mg<br>Days Since C1D1: 14","CTMS-18<br>Basophils (%): 0.6 %<br>2024-07-11 9:05<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 1.76 mg<br>Days Since C1D1: 22","CTMS-18<br>Basophils (%): 1.8 %<br>2024-07-17 9:38<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 1.76 mg<br>Evexomostat: 49 mg/m2, 8 mg<br>Days Since C1D1: 28","CTMS-18<br>Basophils (%): 0.6 %<br>2024-08-01 9:02<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 1.76 mg<br>Evexomostat: 49 mg/m2, 78 mg<br>Days Since C1D1: 43","CTMS-18<br>Basophils (%): 1.3 %<br>2024-08-07 8:22<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 1.76 mg<br>Days Since C1D1: 49","CTMS-18<br>Basophils (%): 1.8 %<br>2024-08-14 4:57<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 78 mg<br>Days Since C1D1: 56","CTMS-18<br>Basophils (%): 0.6 %<br>2024-09-03 0:21<br>Visit: End of Treatment<br>Days Since C1D1: 76"],"textposition":"top right","text":["","Both","","Ev","Er","Both","Both","Er","Ev",""],"line":{"color":"orange","width":2},"marker":{"symbol":"diamond","size":9,"color":"orange"},"inherit":true},"295c5793b8d.19":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-14,0,7,21,28,35,49,56],"y":[0,0.59999999999999998,2,0.29999999999999999,0.69999999999999996,0.40000000000000002,0.29999999999999999,0.80000000000000004],"name":"CTMS-19","legendgroup":"CTMS-19","hoverinfo":"text","hovertext":["CTMS-19<br>Basophils (%): 0 %<br>2024-09-04 8:50<br>Visit: Screening<br>Days Since C1D1: -14","CTMS-19<br>Basophils (%): 0.6 %<br>2024-09-18 9:54<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 0","CTMS-19<br>Basophils (%): 2 %<br>2024-09-25 0:00<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 7","CTMS-19<br>Basophils (%): 0.3 %<br>2024-10-09 0:19<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 21","CTMS-19<br>Basophils (%): 0.7 %<br>2024-10-16 8:22<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 28","CTMS-19<br>Basophils (%): 0.4 %<br>2024-10-23 9:12<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 35","CTMS-19<br>Basophils (%): 0.3 %<br>2024-11-06 0:24<br>Visit: Cycle 3 Day 1<br>Days Since C1D1: 49","CTMS-19<br>Basophils (%): 0.8 %<br>2024-11-13 0:08<br>Visit: End of Treatment<br>Days Since C1D1: 56"],"textposition":"top right","text":["","Both","Er","Ev","Er","Both","",""],"line":{"color":"#2222ff","width":2},"marker":{"symbol":"star","size":9,"color":"#2222ff"},"inherit":true},"295c5793b8d.20":{"connectgaps":true,"mode":"lines+markers+text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":[-6,0,8,11,18,28,36,37,56],"y":[1.1000000000000001,0.69999999999999996,1.3,1.51,2,1,1,1,1],"name":"CTMS-20","legendgroup":"CTMS-20","hoverinfo":"text","hovertext":["CTMS-20<br>Basophils (%): 1.1 %<br>2024-12-10 0:02<br>Visit: Screening<br>Days Since C1D1: -6","CTMS-20<br>Basophils (%): 0.7 %<br>2024-12-16 4:03<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 3.2 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 0","CTMS-20<br>Basophils (%): 1.3 %<br>2024-12-24 0:38<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 8","CTMS-20<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 3.2 mg<br>Days Since C1D1: 11","CTMS-20<br>Basophils (%): 2 %<br>2025-01-03 8:45<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 18","CTMS-20<br>Basophils (%): 1 %<br>2025-01-13 8:23<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 2.5 mg<br>Days Since C1D1: 28","CTMS-20<br>Basophils (%): 1 %<br>2025-01-21 6:25<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 36","CTMS-20<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 37","CTMS-20<br>Basophils (%): 1 %<br>2025-02-10 4:28<br>Visit: Cycle 3 Day 1<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 56"],"textposition":"top right","text":["","Both","","Er","Ev","Er","","Both","Ev"],"line":{"color":"#22cc22","width":2},"marker":{"symbol":"star","size":9,"color":"#22cc22"},"inherit":true},"295c5793b8d.21":{"connectgaps":true,"mode":"text","alpha_stroke":1,"sizes":[10,100],"spans":[1,20],"type":"scatter","x":0,"y":1.5,"text":"High","textposition":"bottom left","showlegend":false,"inherit":true}},"layout":{"margin":{"b":40,"l":60,"t":25,"r":10},"title":"Basophils (%) (%)<br><span>Doses marked <b>Er<\/b>ibulin, <b>Ev<\/b>exomostat, <b>Both<\/b><\/span>","xaxis":{"domain":[0,1],"automargin":true,"title":"Days Since C1D1","range":[-42.640000000000001,568.63999999999999]},"yaxis":{"domain":[0,1],"automargin":true,"title":"Basophils (%) (%)","range":[-0.44,11.44]},"legend":{"title":{"text":"Subject"}},"shapes":[{"type":"line","x0":0,"x1":1,"xref":"paper","y0":1.5,"y1":1.5,"yref":"y","line":{"color":"black","dash":"dot"}}],"hovermode":"closest","showlegend":true},"source":"A","config":{"modeBarButtonsToAdd":["hoverclosest","hovercompare"],"showSendToCloud":false},"data":[{"connectgaps":true,"mode":"lines+markers","type":"scatter","marker":{"color":"rgba(31,119,180,1)","line":{"color":"rgba(31,119,180,1)"}},"error_y":{"color":"rgba(31,119,180,1)"},"error_x":{"color":"rgba(31,119,180,1)"},"line":{"color":"rgba(31,119,180,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-8,0,7,14,21,29,42,49,56,64,70,77,92,98,105,113,119,140,147,155,161,168,182,197],"y":[0.59999999999999998,0.80000000000000004,2,2,1.1000000000000001,1,1.2,0.90000000000000002,0.94666666666666677,1,3.2000000000000002,1,0.90000000000000002,2.5,0,0.80000000000000004,0.90000000000000002,0.90000000000000002,1,1,0.80000000000000004,0.80000000000000004,0.80000000000000004,1.5],"name":"CTMS-01","legendgroup":"CTMS-01","hoverinfo":["text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-1<br>Basophils (%): 0.6 %<br>2022-12-13 5:06<br>Visit: Screening<br>Days Since C1D1: -8","CTMS-1<br>Basophils (%): 0.8 %<br>2022-12-21 9:15<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 0","CTMS-1<br>Basophils (%): 2 %<br>2022-12-28 3:08<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 7","CTMS-1<br>Basophils (%): 2 %<br>2023-01-04 0:18<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 14","CTMS-1<br>Basophils (%): 1.1 %<br>2023-01-11 0:37<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 21","CTMS-1<br>Basophils (%): 1 %<br>2023-01-19 0:41<br>Visit: Cycle 2 Day 8<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 29","CTMS-1<br>Basophils (%): 1.2 %<br>2023-02-01 3:01<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 42","CTMS-1<br>Basophils (%): 0.9 %<br>2023-02-08 1:07<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 49","CTMS-1<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 56","CTMS-1<br>Basophils (%): 1 %<br>2023-02-23 9:35<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 64","CTMS-1<br>Basophils (%): 3.2 %<br>2023-03-01 0:26<br>Visit: Cycle 4 Day 8<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 70","CTMS-1<br>Basophils (%): 1 %<br>2023-03-08 1:04<br>Visit: Cycle 4 Day 15<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 77","CTMS-1<br>Basophils (%): 0.9 %<br>2023-03-23 0:26<br>Visit: Cycle 5 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 92","CTMS-1<br>Basophils (%): 2.5 %<br>2023-03-29 2:47<br>Visit: Cycle 5 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 98","CTMS-1<br>Basophils (%): 0 %<br>2023-04-05 0:50<br>Visit: Cycle 5 Day 15<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 105","CTMS-1<br>Basophils (%): 0.8 %<br>2023-04-13 8:55<br>Visit: Cycle 6 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 113","CTMS-1<br>Basophils (%): 0.9 %<br>2023-04-19 3:04<br>Visit: Cycle 6 Day 8<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 119","CTMS-1<br>Basophils (%): 0.9 %<br>2023-05-10 0:47<br>Visit: Cycle 7 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 140","CTMS-1<br>Basophils (%): 1 %<br>2023-05-17 8:57<br>Visit: Cycle 7 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 147","CTMS-1<br>Basophils (%): 1 %<br>2023-05-25 9:26<br>Visit: Cycle 7 Day 15<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 155","CTMS-1<br>Basophils (%): 0.8 %<br>2023-05-31 9:59<br>Visit: Cycle 8 Day 1<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Days Since C1D1: 161","CTMS-1<br>Basophils (%): 0.8 %<br>2023-06-07 9:33<br>Visit: Cycle 8 Day 8<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 168","CTMS-1<br>Basophils (%): 0.8 %<br>2023-06-21 9:37<br>Visit: Cycle 9 Day 1<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 182","CTMS-1<br>Basophils (%): 1.5 %<br>2023-07-06 9:54<br>Visit: End of Treatment<br>Days Since C1D1: 197"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","Ev","Both","Er","Ev","Er","Ev","Er","Both","Er","Ev","Er","Ev","Both","Er","Ev","Er","Both","Both",""],"line":{"color":"#2222ff","width":2},"marker":{"color":"#2222ff","symbol":"circle","size":9,"line":{"color":"rgba(255,127,14,1)"}},"error_y":{"color":"rgba(255,127,14,1)"},"error_x":{"color":"rgba(255,127,14,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-4,0,7,14,21,28,42,49,79,91],"y":[2.8999999999999999,2.9727272727272727,3.1000000000000001,11,1,4,0,3,1.2,1.6000000000000001],"name":"CTMS-02","legendgroup":"CTMS-02","hoverinfo":["text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-2<br>Basophils (%): 2.9 %<br>2022-10-27 7:54<br>Visit: Screening<br>Days Since C1D1: -4","CTMS-2<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 3 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 0","CTMS-2<br>Basophils (%): 3.1 %<br>2022-11-07 0:21<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 3 mg<br>Days Since C1D1: 7","CTMS-2<br>Basophils (%): 11 %<br>2022-11-14 7:44<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 14","CTMS-2<br>Basophils (%): 1 %<br>2022-11-21 3:30<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 3 mg<br>Days Since C1D1: 21","CTMS-2<br>Basophils (%): 4 %<br>2022-11-28 7:13<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 3 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 28","CTMS-2<br>Basophils (%): 0 %<br>2022-12-12 3:29<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 2.4 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 42","CTMS-2<br>Basophils (%): 3 %<br>2022-12-19 5:47<br>Visit: Cycle 3 Day 8<br>Days Since C1D1: 49","CTMS-2<br>Basophils (%): 1.2 %<br>2023-01-18 9:46<br>Visit: Cycle 5 Day 1<br>Eribulin: 0.7 mg/m2, 1.4 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 79","CTMS-2<br>Basophils (%): 1.6 %<br>2023-01-30 9:04<br>Visit: End of Treatment<br>Days Since C1D1: 91"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","Both","Both","","Both",""],"line":{"color":"#22cc22","width":2},"marker":{"color":"#22cc22","symbol":"circle","size":9,"line":{"color":"rgba(44,160,44,1)"}},"error_y":{"color":"rgba(44,160,44,1)"},"error_x":{"color":"rgba(44,160,44,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-8,0,7,14,21,28,42,49,56,63,70,84],"y":[0.29999999999999999,0.20000000000000001,2.3999999999999999,1.3,0.40000000000000002,1,0.29999999999999999,0,1.3999999999999999,0.29999999999999999,0,0.20000000000000001],"name":"CTMS-03","legendgroup":"CTMS-03","hoverinfo":["text","text","text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-3<br>Basophils (%): 0.3 %<br>2023-01-25 2:07<br>Visit: Screening<br>Days Since C1D1: -8","CTMS-3<br>Basophils (%): 0.2 %<br>2023-02-02 2:17<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 0","CTMS-3<br>Basophils (%): 2.4 %<br>2023-02-09 5:19<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Days Since C1D1: 7","CTMS-3<br>Basophils (%): 1.3 %<br>2023-02-16 8:42<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 14","CTMS-3<br>Basophils (%): 0.4 %<br>2023-02-23 8:56<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Days Since C1D1: 21","CTMS-3<br>Basophils (%): 1 %<br>2023-03-02 1:40<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 28","CTMS-3<br>Basophils (%): 0.3 %<br>2023-03-16 9:59<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 42","CTMS-3<br>Basophils (%): 0 %<br>2023-03-23 3:27<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Days Since C1D1: 49","CTMS-3<br>Basophils (%): 1.4 %<br>2023-03-30 3:47<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 56","CTMS-3<br>Basophils (%): 0.3 %<br>2023-04-06 9:37<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Days Since C1D1: 63","CTMS-3<br>Basophils (%): 0 %<br>2023-04-13 1:46<br>Visit: Cycle 4 Day 8<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 70","CTMS-3<br>Basophils (%): 0.2 %<br>2023-04-27 9:55<br>Visit: End of Treatment<br>Days Since C1D1: 84"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","Both","Both","Er","Ev","Er","Both",""],"line":{"color":"black","width":2},"marker":{"color":"black","symbol":"circle","size":9,"line":{"color":"rgba(214,39,40,1)"}},"error_y":{"color":"rgba(214,39,40,1)"},"error_x":{"color":"rgba(214,39,40,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-1,0,7,26],"y":[0.5,0.40000000000000002,2,0.59999999999999998],"name":"CTMS-04","legendgroup":"CTMS-04","hoverinfo":["text","text","text","text"],"hovertext":["CTMS-4<br>Basophils (%): 0.5 %<br>2023-03-01 9:16<br>Visit: Screening<br>Days Since C1D1: -1","CTMS-4<br>Basophils (%): 0.4 %<br>2023-03-02 1:58<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.3 mg<br>Evexomostat: 49 mg/m2, 80 mg<br>Days Since C1D1: 0","CTMS-4<br>Basophils (%): 2 %<br>2023-03-09 2:52<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 7","CTMS-4<br>Basophils (%): 0.6 %<br>2023-03-28 2:44<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 80 mg<br>Days Since C1D1: 26"],"textposition":["top right","top right","top right","top right"],"text":["","Both","","Ev"],"line":{"color":"#ff7777","width":2},"marker":{"color":"#ff7777","symbol":"circle","size":9,"line":{"color":"rgba(148,103,189,1)"}},"error_y":{"color":"rgba(148,103,189,1)"},"error_x":{"color":"rgba(148,103,189,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-8,0,7,14,21,29,43,50,64,71,78,85,106],"y":[1,0.69999999999999996,1,1,1.3,0.90000000000000002,0.80000000000000004,0.29999999999999999,0.5,0.69999999999999996,0.90000000000000002,1,0.40000000000000002],"name":"CTMS-05","legendgroup":"CTMS-05","hoverinfo":["text","text","text","text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-5<br>Basophils (%): 1 %<br>2023-03-21 9:53<br>Visit: Screening<br>Days Since C1D1: -8","CTMS-5<br>Basophils (%): 0.7 %<br>2023-03-29 8:55<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.9 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 0","CTMS-5<br>Basophils (%): 1 %<br>2023-04-05 0:35<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.9 mg<br>Days Since C1D1: 7","CTMS-5<br>Basophils (%): 1 %<br>2023-04-12 2:16<br>Visit: Cycle 1 Day 15<br>Days Since C1D1: 14","CTMS-5<br>Basophils (%): 1.3 %<br>2023-04-19 8:43<br>Visit: Cycle 2 Day 1<br>Days Since C1D1: 21","CTMS-5<br>Basophils (%): 0.9 %<br>2023-04-27 9:38<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 29","CTMS-5<br>Basophils (%): 0.8 %<br>2023-05-11 9:25<br>Visit: Cycle 3 Day 1<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 43","CTMS-5<br>Basophils (%): 0.3 %<br>2023-05-18 8:22<br>Visit: Cycle 3 Day 8<br>Days Since C1D1: 50","CTMS-5<br>Basophils (%): 0.5 %<br>2023-06-01 2:18<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 75 mg<br>Days Since C1D1: 64","CTMS-5<br>Basophils (%): 0.7 %<br>2023-06-08 8:42<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.1 mg/m2, 2.3 mg<br>Days Since C1D1: 71","CTMS-5<br>Basophils (%): 0.9 %<br>2023-06-15 8:24<br>Visit: Cycle 4 Day 8<br>Days Since C1D1: 78","CTMS-5<br>Basophils (%): 1 %<br>2023-06-22 8:35<br>Visit: Cycle 4 Day 15<br>Evexomostat: 49 mg/m2, 75 mg<br>Days Since C1D1: 85","CTMS-5<br>Basophils (%): 0.4 %<br>2023-07-13 9:43<br>Visit: End of Treatment<br>Days Since C1D1: 106"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","","","","Ev","","Ev","Er","","Ev",""],"line":{"color":"#ff00ff","width":2},"marker":{"color":"#ff00ff","symbol":"circle","size":9,"line":{"color":"rgba(140,86,75,1)"}},"error_y":{"color":"rgba(140,86,75,1)"},"error_x":{"color":"rgba(140,86,75,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-17,0,7,18,26,35,78],"y":[0.29999999999999999,0.40000000000000002,0.59999999999999998,0.29999999999999999,0.40000000000000002,0.20000000000000001,0.29999999999999999],"name":"CTMS-06","legendgroup":"CTMS-06","hoverinfo":["text","text","text","text","text","text","text"],"hovertext":["CTMS-6<br>Basophils (%): 0.3 %<br>2023-06-19 0:54<br>Visit: Screening<br>Days Since C1D1: -17","CTMS-6<br>Basophils (%): 0.4 %<br>2023-07-06 2:36<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 3.4 mg<br>Evexomostat: 49 mg/m2, 120 mg<br>Days Since C1D1: 0","CTMS-6<br>Basophils (%): 0.6 %<br>2023-07-13 9:41<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 3.4 mg<br>Days Since C1D1: 7","CTMS-6<br>Basophils (%): 0.3 %<br>2023-07-24 9:24<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 120 mg<br>Days Since C1D1: 18","CTMS-6<br>Basophils (%): 0.4 %<br>2023-08-01 0:54<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 2.6 mg<br>Days Since C1D1: 26","CTMS-6<br>Basophils (%): 0.2 %<br>2023-08-10 2:03<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 2.6 mg<br>Evexomostat: 49 mg/m2, 120 mg<br>Days Since C1D1: 35","CTMS-6<br>Basophils (%): 0.3 %<br>2023-09-22 8:56<br>Visit: End of Treatment<br>Days Since C1D1: 78"],"textposition":["top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","Both",""],"line":{"color":"orange","width":2},"marker":{"color":"orange","symbol":"circle","size":9,"line":{"color":"rgba(227,119,194,1)"}},"error_y":{"color":"rgba(227,119,194,1)"},"error_x":{"color":"rgba(227,119,194,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-5,0,7,16,28,35,49,56,65,70,77,98,105,112,119,126,140,147,154,161,168,185,189,199,203,210,224,231,238,245,252,266,273,280,287,295,308,315,322,336,343,350,357,364,378,385,392,399,406,420,428,434,441,448,462,469,476,483,490,504,511,520,525,533,546],"y":[0.5,0.59999999999999998,1,0,1.7,0,1,3.2000000000000002,0,1.5,0.80000000000000004,0.80000000000000004,0.59999999999999998,0.90000000000000002,0.69999999999999996,0.69999999999999996,0.69999999999999996,1,0.59999999999999998,0.40000000000000002,0.69999999999999996,0.69999999999999996,1,0.59999999999999998,1.1000000000000001,0.29999999999999999,0.59999999999999998,0.69999999999999996,0.20000000000000001,0.5,0.29999999999999999,0.59999999999999998,0.29999999999999999,0.59999999999999998,0.29999999999999999,0.40000000000000002,0.80000000000000004,0.59999999999999998,0.59999999999999998,0.69999999999999996,0.80000000000000004,1,0.5,0.69999999999999996,0.69999999999999996,1,0.80000000000000004,0,0.59999999999999998,0.5,0.29999999999999999,0,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.40000000000000002,0.5,0.69999999999999996,0.40000000000000002,0.40000000000000002],"name":"CTMS-07","legendgroup":"CTMS-07","hoverinfo":["text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-7<br>Basophils (%): 0.5 %<br>2023-06-28 9:48<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-7<br>Basophils (%): 0.6 %<br>2023-07-03 2:08<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.3 mg<br>Evexomostat: 49 mg/m2, 80 mg<br>Days Since C1D1: 0","CTMS-7<br>Basophils (%): 1 %<br>2023-07-10 4:05<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.3 mg<br>Days Since C1D1: 7","CTMS-7<br>Basophils (%): 0 %<br>2023-07-19 4:32<br>Visit: Cycle 1 Day 15<br>Days Since C1D1: 16","CTMS-7<br>Basophils (%): 1.7 %<br>2023-07-31 1:51<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 28","CTMS-7<br>Basophils (%): 0 %<br>2023-08-07 1:05<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 35","CTMS-7<br>Basophils (%): 1 %<br>2023-08-21 9:54<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 49","CTMS-7<br>Basophils (%): 3.2 %<br>2023-08-28 0:56<br>Visit: Cycle 3 Day 8<br>Days Since C1D1: 56","CTMS-7<br>Basophils (%): 0 %<br>2023-09-06 9:36<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 65","CTMS-7<br>Basophils (%): 1.5 %<br>2023-09-11 0:22<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.4 mg/m2, 1.1 mg<br>Days Since C1D1: 70","CTMS-7<br>Basophils (%): 0.8 %<br>2023-09-18 5:44<br>Visit: Cycle 4 Day 8<br>Eribulin: 1.4 mg/m2, 1.1 mg<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 77","CTMS-7<br>Basophils (%): 0.8 %<br>2023-10-09 9:36<br>Visit: Cycle 5 Day 1<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 98","CTMS-7<br>Basophils (%): 0.6 %<br>2023-10-16 9:47<br>Visit: Cycle 5 Day 8<br>Days Since C1D1: 105","CTMS-7<br>Basophils (%): 0.9 %<br>2023-10-23 8:46<br>Visit: Cycle 5 Day 15<br>Days Since C1D1: 112","CTMS-7<br>Basophils (%): 0.7 %<br>2023-10-30 9:57<br>Visit: Cycle 6 Day 1<br>Days Since C1D1: 119","CTMS-7<br>Basophils (%): 0.7 %<br>2023-11-06 8:45<br>Visit: Cycle 6 Day 8<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 126","CTMS-7<br>Basophils (%): 0.7 %<br>2023-11-20 8:38<br>Visit: Cycle 7 Day 1<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 140","CTMS-7<br>Basophils (%): 1 %<br>2023-11-27 5:28<br>Visit: Cycle 7 Day 8<br>Days Since C1D1: 147","CTMS-7<br>Basophils (%): 0.6 %<br>2023-12-04 5:29<br>Visit: Cycle 7 Day 15<br>Evexomostat: 49 mg/m2, 60 mg<br>Days Since C1D1: 154","CTMS-7<br>Basophils (%): 0.4 %<br>2023-12-11 8:53<br>Visit: Cycle 8 Day 1<br>Days Since C1D1: 161","CTMS-7<br>Basophils (%): 0.7 %<br>2023-12-18 0:20<br>Visit: Cycle 8 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 168","CTMS-7<br>Basophils (%): 0.7 %<br>2024-01-04 1:10<br>Visit: Cycle 9 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 185","CTMS-7<br>Basophils (%): 1 %<br>2024-01-08 5:43<br>Visit: Cycle 9 Day 8<br>Days Since C1D1: 189","CTMS-7<br>Basophils (%): 0.6 %<br>2024-01-18 0:07<br>Visit: Cycle 9 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 199","CTMS-7<br>Basophils (%): 1.1 %<br>2024-01-22 5:46<br>Visit: Cycle 10 Day 1<br>Days Since C1D1: 203","CTMS-7<br>Basophils (%): 0.3 %<br>2024-01-29 4:41<br>Visit: Cycle 1 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 210","CTMS-7<br>Basophils (%): 0.6 %<br>2024-02-12 5:02<br>Visit: Cycle 11 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 224","CTMS-7<br>Basophils (%): 0.7 %<br>2024-02-19 4:36<br>Visit: Cycle 11 Day 8<br>Days Since C1D1: 231","CTMS-7<br>Basophils (%): 0.2 %<br>2024-02-26 9:11<br>Visit: Cycle 11 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 238","CTMS-7<br>Basophils (%): 0.5 %<br>2024-03-04 9:16<br>Visit: Cycle 12 Day 1<br>Days Since C1D1: 245","CTMS-7<br>Basophils (%): 0.3 %<br>2024-03-11 8:28<br>Visit: Cycle 12 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 252","CTMS-7<br>Basophils (%): 0.6 %<br>2024-03-25 8:57<br>Visit: Cycle 13 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 266","CTMS-7<br>Basophils (%): 0.3 %<br>2024-04-01 9:55<br>Visit: Cycle 13 Day 8<br>Days Since C1D1: 273","CTMS-7<br>Basophils (%): 0.6 %<br>2024-04-08 9:30<br>Visit: Cycle 13 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 280","CTMS-7<br>Basophils (%): 0.3 %<br>2024-04-15 3:12<br>Visit: Cycle 14 Day 1<br>Days Since C1D1: 287","CTMS-7<br>Basophils (%): 0.4 %<br>2024-04-23 8:13<br>Visit: Cycle 14 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 295","CTMS-7<br>Basophils (%): 0.8 %<br>2024-05-06 9:25<br>Visit: Cycle 15 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 308","CTMS-7<br>Basophils (%): 0.6 %<br>2024-05-13 9:54<br>Visit: Cycle 15 Day 8<br>Days Since C1D1: 315","CTMS-7<br>Basophils (%): 0.6 %<br>2024-05-20 0:45<br>Visit: Cycle 15 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 322","CTMS-7<br>Basophils (%): 0.7 %<br>2024-06-03 0:34<br>Visit: Cycle 16 Day 1<br>Eribulin: 0.7 mg/m2, 1.1 mg<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 336","CTMS-7<br>Basophils (%): 0.8 %<br>2024-06-10 8:52<br>Visit: Cycle 16 Day 8<br>Eribulin: 0.7 mg/m2, 1.1 mg<br>Days Since C1D1: 343","CTMS-7<br>Basophils (%): 1 %<br>2024-06-17 9:17<br>Visit: Cycle 16 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 350","CTMS-7<br>Basophils (%): 0.5 %<br>2024-06-24 0:21<br>Visit: Cycle 17 Day 1<br>Eribulin: 0.7 mg/m2, 1.1 mg<br>Days Since C1D1: 357","CTMS-7<br>Basophils (%): 0.7 %<br>2024-07-01 9:17<br>Visit: Cycle 17 Day 8<br>Days Since C1D1: 364","CTMS-7<br>Basophils (%): 0.7 %<br>2024-07-15 1:58<br>Visit: Cycle 18 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 378","CTMS-7<br>Basophils (%): 1 %<br>2024-07-22 9:42<br>Visit: Cycle 18 Day 8<br>Days Since C1D1: 385","CTMS-7<br>Basophils (%): 0.8 %<br>2024-07-29 9:32<br>Visit: Cycle 18 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 392","CTMS-7<br>Basophils (%): 0 %<br>2024-08-05 9:35<br>Visit: Cycle 19 Day 1<br>Days Since C1D1: 399","CTMS-7<br>Basophils (%): 0.6 %<br>2024-08-12 9:28<br>Visit: Cycle 19 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 406","CTMS-7<br>Basophils (%): 0.5 %<br>2024-08-26 9:12<br>Visit: Cycle 20 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 420","CTMS-7<br>Basophils (%): 0.3 %<br>2024-09-03 8:21<br>Visit: Cycle 20 Day 8<br>Days Since C1D1: 428","CTMS-7<br>Basophils (%): 0 %<br>2024-09-09 9:24<br>Visit: Cycle 20 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 434","CTMS-7<br>Basophils (%): 0.4 %<br>2024-09-16 8:21<br>Visit: Cycle 21 Day 1<br>Days Since C1D1: 441","CTMS-7<br>Basophils (%): 0.4 %<br>2024-09-23 1:02<br>Visit: Cycle 21 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 448","CTMS-7<br>Basophils (%): 0.4 %<br>2024-10-07 9:34<br>Visit: Cycle 22 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 462","CTMS-7<br>Basophils (%): 0.4 %<br>2024-10-14 1:41<br>Visit: Cycle 22 Day 8<br>Days Since C1D1: 469","CTMS-7<br>Basophils (%): 0.4 %<br>2024-10-21 8:48<br>Visit: Cycle 22 Day 15<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 476","CTMS-7<br>Basophils (%): 0.4 %<br>2024-10-28 8:28<br>Visit: Cycle 23 Day 1<br>Days Since C1D1: 483","CTMS-7<br>Basophils (%): 0.4 %<br>2024-11-04 9:03<br>Visit: Cycle 23 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 490","CTMS-7<br>Basophils (%): 0.4 %<br>2024-11-18 0:16<br>Visit: Cycle 24 Day 1<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 504","CTMS-7<br>Basophils (%): 0.4 %<br>2024-11-25 9:24<br>Visit: NA<br>Days Since C1D1: 511","CTMS-7<br>Basophils (%): 0.5 %<br>2024-12-04 5:25<br>Visit: Cycle 24 Day 8<br>Evexomostat: 49 mg/m2, 55 mg<br>Days Since C1D1: 520","CTMS-7<br>Basophils (%): 0.7 %<br>2024-12-09 0:12<br>Visit: NA<br>Days Since C1D1: 525","CTMS-7<br>Basophils (%): 0.4 %<br>2024-12-17 4:27<br>Visit: Cycle 25 Day 8<br>Evexomostat: 49 mg/m2, 50 mg<br>Days Since C1D1: 533","CTMS-7<br>Basophils (%): 0.4 %<br>2024-12-30 9:07<br>Visit: End of Treatment<br>Days Since C1D1: 546"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","","Both","Er","Both","","Ev","Er","Both","Ev","","","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","Both","Er","Ev","Er","","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev","Ev","","Ev","","Ev",""],"line":{"color":"#2222ff","width":2},"marker":{"color":"#2222ff","symbol":"square","size":9,"line":{"color":"rgba(127,127,127,1)"}},"error_y":{"color":"rgba(127,127,127,1)"},"error_x":{"color":"rgba(127,127,127,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-3,0,7,14,22,29,42,50,57,64,70,85],"y":[0.5,0.29999999999999999,2,0,0.5,1.3999999999999999,0.5,2.7999999999999998,1,0,0,0.80000000000000004],"name":"CTMS-08","legendgroup":"CTMS-08","hoverinfo":["text","text","text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-8<br>Basophils (%): 0.5 %<br>2023-07-03 2:21<br>Visit: Screening<br>Days Since C1D1: -3","CTMS-8<br>Basophils (%): 0.3 %<br>2023-07-06 4:41<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 0","CTMS-8<br>Basophils (%): 2 %<br>2023-07-13 2:57<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 7","CTMS-8<br>Basophils (%): 0 %<br>2023-07-20 9:10<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 14","CTMS-8<br>Basophils (%): 0.5 %<br>2023-07-28 8:25<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 22","CTMS-8<br>Basophils (%): 1.4 %<br>2023-08-04 8:43<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 29","CTMS-8<br>Basophils (%): 0.5 %<br>2023-08-17 3:53<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 2.2 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 42","CTMS-8<br>Basophils (%): 2.8 %<br>2023-08-25 0:09<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 2.2 mg<br>Days Since C1D1: 50","CTMS-8<br>Basophils (%): 1 %<br>2023-09-01 1:27<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 57","CTMS-8<br>Basophils (%): 0 %<br>2023-09-08 0:36<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.1 mg/m2, 2.2 mg<br>Days Since C1D1: 64","CTMS-8<br>Basophils (%): 0 %<br>2023-09-14 4:52<br>Visit: Cycle 4 Day 8<br>Days Since C1D1: 70","CTMS-8<br>Basophils (%): 0.8 %<br>2023-09-29 9:00<br>Visit: End of Treatment<br>Days Since C1D1: 85"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","","Both","Er","Ev","Er","",""],"line":{"color":"#22cc22","width":2},"marker":{"color":"#22cc22","symbol":"square","size":9,"line":{"color":"rgba(188,189,34,1)"}},"error_y":{"color":"rgba(188,189,34,1)"},"error_x":{"color":"rgba(188,189,34,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-7,0,7],"y":[0.20000000000000001,0.40000000000000002,2.2999999999999998],"name":"CTMS-09","legendgroup":"CTMS-09","hoverinfo":["text","text","text"],"hovertext":["CTMS-9<br>Basophils (%): 0.2 %<br>2023-07-03 2:17<br>Visit: Screening<br>Days Since C1D1: -7","CTMS-9<br>Basophils (%): 0.4 %<br>2023-07-10 0:28<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Evexomostat: 49 mg/m2, 95 mg<br>Days Since C1D1: 0","CTMS-9<br>Basophils (%): 2.3 %<br>2023-07-17 1:47<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.7 mg<br>Days Since C1D1: 7"],"textposition":["top right","top right","top right"],"text":["","Both","Er"],"line":{"color":"black","width":2},"marker":{"color":"black","symbol":"square","size":9,"line":{"color":"rgba(23,190,207,1)"}},"error_y":{"color":"rgba(23,190,207,1)"},"error_x":{"color":"rgba(23,190,207,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-5,0,7,14],"y":[0.29999999999999999,0.40000000000000002,1,0.90000000000000002],"name":"CTMS-10","legendgroup":"CTMS-10","hoverinfo":["text","text","text","text"],"hovertext":["CTMS-10<br>Basophils (%): 0.3 %<br>2023-11-10 0:39<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-10<br>Basophils (%): 0.4 %<br>2023-11-15 1:07<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 3.1 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 0","CTMS-10<br>Basophils (%): 1 %<br>2023-11-22 1:06<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 3.1 mg<br>Days Since C1D1: 7","CTMS-10<br>Basophils (%): 0.9 %<br>2023-11-29 9:46<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 14"],"textposition":["top right","top right","top right","top right"],"text":["","Both","Er","Ev"],"line":{"color":"#ff7777","width":2},"marker":{"color":"#ff7777","symbol":"square","size":9,"line":{"color":"rgba(31,119,180,1)"}},"error_y":{"color":"rgba(31,119,180,1)"},"error_x":{"color":"rgba(31,119,180,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-1,0,7,14,20,27,41,48,55,69,71,78,83,90,97,111,117,139,146,153,161],"y":[0.40000000000000002,0.5,1.8,0.93846153846153868,0.20000000000000001,2.7999999999999998,0.29999999999999999,0.29999999999999999,1.3,0.5,0.54444444444444429,0.69999999999999996,1,0.20000000000000001,0.59999999999999998,0.40000000000000002,0.5,0.80000000000000004,0.59999999999999998,1,0.20000000000000001],"name":"CTMS-11","legendgroup":"CTMS-11","hoverinfo":["text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-11<br>Basophils (%): 0.4 %<br>2024-01-16 8:25<br>Visit: Screening<br>Days Since C1D1: -1","CTMS-11<br>Basophils (%): 0.5 %<br>2024-01-17 9:00<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 0","CTMS-11<br>Basophils (%): 1.8 %<br>2024-01-24 0:12<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Days Since C1D1: 7","CTMS-11<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 14","CTMS-11<br>Basophils (%): 0.2 %<br>2024-02-06 9:13<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.4 mg<br>Days Since C1D1: 20","CTMS-11<br>Basophils (%): 2.8 %<br>2024-02-13 0:40<br>Visit: Cycle 2 Day 8<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 27","CTMS-11<br>Basophils (%): 0.3 %<br>2024-02-27 8:35<br>Visit: Cycle 3 Day 1<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 41","CTMS-11<br>Basophils (%): 0.3 %<br>2024-03-05 8:35<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Days Since C1D1: 48","CTMS-11<br>Basophils (%): 1.3 %<br>2024-03-12 8:24<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 55","CTMS-11<br>Basophils (%): 0.5 %<br>2024-03-26 0:43<br>Visit: Cycle 4 Day 1<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 69","CTMS-11<br>Visit: Cycle 4 Day 1<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 71","CTMS-11<br>Basophils (%): 0.7 %<br>2024-04-04 7:58<br>Visit: Cycle 4 Day 8<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 78","CTMS-11<br>Basophils (%): 1 %<br>2024-04-09 6:37<br>Visit: Cycle 4 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 83","CTMS-11<br>Basophils (%): 0.2 %<br>2024-04-16 1:17<br>Visit: Cycle 5 Day 1<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 90","CTMS-11<br>Basophils (%): 0.6 %<br>2024-04-23 8:27<br>Visit: Cycle 5 Day 8<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 97","CTMS-11<br>Basophils (%): 0.4 %<br>2024-05-07 0:51<br>Visit: Cycle 6 Day 1<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 111","CTMS-11<br>Basophils (%): 0.5 %<br>2024-05-13 7:51<br>Visit: Cycle 6 Day 8<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 117","CTMS-11<br>Basophils (%): 0.8 %<br>2024-06-04 1:40<br>Visit: Cycle 7 Day 1<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 139","CTMS-11<br>Basophils (%): 0.6 %<br>2024-06-11 1:30<br>Visit: Cycle 7 Day 8<br>Eribulin: 0.7 mg/m2, 1.2 mg<br>Days Since C1D1: 146","CTMS-11<br>Basophils (%): 1 %<br>2024-06-18 2:22<br>Visit: Cycle 7 Day 15<br>Evexomostat: 49 mg/m2, 80 mg<br>Days Since C1D1: 153","CTMS-11<br>Basophils (%): 0.2 %<br>2024-06-26 0:31<br>Visit: End of Treatment<br>Days Since C1D1: 161"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","Ev","Ev","Er","Ev","Ev","Er","Er","Ev","Er","Both","Both","Er","Ev","Er","Ev",""],"line":{"color":"#ff00ff","width":2},"marker":{"color":"#ff00ff","symbol":"square","size":9,"line":{"color":"rgba(255,127,14,1)"}},"error_y":{"color":"rgba(255,127,14,1)"},"error_x":{"color":"rgba(255,127,14,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-5,0,13,20,26,27,34,47,48,54,55,61,62,69,76,89,90,97,99,104,110,111,118,132,139,146,153,160,174,181,188,195,202,216,223,230,245],"y":[0.29999999999999999,0.80000000000000004,0.10000000000000001,0.26153846153846161,0.40000000000000002,0.58750000000000036,1.8999999999999999,2.7000000000000002,2.7999999999999998,3.3999999999999999,2.914285714285711,0,0.049999999999999822,0.40000000000000002,2.6000000000000001,2.6000000000000001,2.5875000000000004,2.5,1.928571428571427,0.5,1,1.125,2,1.5,2.2000000000000002,4,0.69999999999999996,2.3999999999999999,0.90000000000000002,1,1.8999999999999999,0.59999999999999998,2.3999999999999999,1,2.2000000000000002,3,1.8999999999999999],"name":"CTMS-12","legendgroup":"CTMS-12","hoverinfo":["text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-12<br>Basophils (%): 0.3 %<br>2024-01-12 2:35<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-12<br>Basophils (%): 0.8 %<br>2024-01-17 0:49<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 0","CTMS-12<br>Basophils (%): 0.1 %<br>2024-01-30 4:03<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 13","CTMS-12<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 20","CTMS-12<br>Basophils (%): 0.4 %<br>2024-02-12 6:34<br>Visit: Cycle 2 Day 1<br>Days Since C1D1: 26","CTMS-12<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Days Since C1D1: 27","CTMS-12<br>Basophils (%): 1.9 %<br>2024-02-20 0:43<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 34","CTMS-12<br>Basophils (%): 2.7 %<br>2024-03-04 6:30<br>Visit: Cycle 3 Day 1<br>Days Since C1D1: 47","CTMS-12<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 48","CTMS-12<br>Basophils (%): 3.4 %<br>2024-03-11 6:26<br>Visit: Cycle 3 Day 8<br>Days Since C1D1: 54","CTMS-12<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Days Since C1D1: 55","CTMS-12<br>Basophils (%): 0 %<br>2024-03-18 6:12<br>Visit: Cycle 3 Day 15<br>Days Since C1D1: 61","CTMS-12<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 62","CTMS-12<br>Basophils (%): 0.4 %<br>2024-03-26 0:29<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 69","CTMS-12<br>Basophils (%): 2.6 %<br>2024-04-02 0:37<br>Visit: Cycle 4 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 76","CTMS-12<br>Basophils (%): 2.6 %<br>2024-04-15 6:00<br>Visit: NA<br>Days Since C1D1: 89","CTMS-12<br>Visit: Cycle 5 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 90","CTMS-12<br>Basophils (%): 2.5 %<br>2024-04-23 0:01<br>Visit: Cycle 5 Day 8<br>Days Since C1D1: 97","CTMS-12<br>Visit: Cycle 5 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 99","CTMS-12<br>Basophils (%): 0.5 %<br>2024-04-30 9:44<br>Visit: Cycle 5 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 104","CTMS-12<br>Basophils (%): 1 %<br>2024-05-06 6:40<br>Visit: NA<br>Days Since C1D1: 110","CTMS-12<br>Visit: Cycle 6 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 111","CTMS-12<br>Basophils (%): 2 %<br>2024-05-14 0:37<br>Visit: Cycle 6 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 118","CTMS-12<br>Basophils (%): 1.5 %<br>2024-05-28 1:31<br>Visit: Cycle 7 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 132","CTMS-12<br>Basophils (%): 2.2 %<br>2024-06-04 0:02<br>Visit: Cycle 7 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 139","CTMS-12<br>Basophils (%): 4 %<br>2024-06-11 0:22<br>Visit: Cycle 7 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 146","CTMS-12<br>Basophils (%): 0.7 %<br>2024-06-18 9:05<br>Visit: Cycle 8 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 153","CTMS-12<br>Basophils (%): 2.4 %<br>2024-06-25 9:38<br>Visit: Cycle 8 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 160","CTMS-12<br>Basophils (%): 0.9 %<br>2024-07-09 9:23<br>Visit: Cycle 9 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 174","CTMS-12<br>Basophils (%): 1 %<br>2024-07-16 9:53<br>Visit: Cycle 9 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 181","CTMS-12<br>Basophils (%): 1.9 %<br>2024-07-23 0:18<br>Visit: Cycle 9 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 188","CTMS-12<br>Basophils (%): 0.6 %<br>2024-07-30 0:59<br>Visit: Cycle 10 Day 1<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Days Since C1D1: 195","CTMS-12<br>Basophils (%): 2.4 %<br>2024-08-06 9:50<br>Visit: Cycle 10 Day 8<br>Eribulin: 1.1 mg/m2, 1.8 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 202","CTMS-12<br>Basophils (%): 1 %<br>2024-08-20 0:39<br>Visit: Cycle 11 Day 1<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 216","CTMS-12<br>Basophils (%): 2.2 %<br>2024-08-27 8:54<br>Visit: Cycle 11 Day 8<br>Eribulin: 1.1 mg/m2, 1.9 mg<br>Days Since C1D1: 223","CTMS-12<br>Basophils (%): 3 %<br>2024-09-03 9:27<br>Visit: Cycle 11 Day 15<br>Evexomostat: 49 mg/m2, 85 mg<br>Days Since C1D1: 230","CTMS-12<br>Basophils (%): 1.9 %<br>2024-09-18 9:12<br>Visit: End of Treatment<br>Days Since C1D1: 245"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","","Er","Both","","Both","","Er","","Ev","Er","Both","","Both","","Er","Ev","","Er","Both","Both","Er","Ev","Er","Both","Both","Er","Ev","Er","Both","Both","Er","Ev",""],"line":{"color":"orange","width":2},"marker":{"color":"orange","symbol":"square","size":9,"line":{"color":"rgba(44,160,44,1)"}},"error_y":{"color":"rgba(44,160,44,1)"},"error_x":{"color":"rgba(44,160,44,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-7,0,8,14,21,27,28,42,49,56,63,70,84],"y":[0.59999999999999998,0.40000000000000002,2.1000000000000001,1,0.90000000000000002,0.5,0.50666666666666671,0.59999999999999998,0.5,0.10000000000000001,0.29999999999999999,0.39999999999999991,0.59999999999999998],"name":"CTMS-13","legendgroup":"CTMS-13","hoverinfo":["text","text","text","text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-13<br>Basophils (%): 0.6 %<br>2024-01-17 9:44<br>Visit: Screening<br>Days Since C1D1: -7","CTMS-13<br>Basophils (%): 0.4 %<br>2024-01-24 8:50<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 0","CTMS-13<br>Basophils (%): 2.1 %<br>2024-02-01 4:50<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Days Since C1D1: 8","CTMS-13<br>Basophils (%): 1 %<br>2024-02-07 2:40<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 14","CTMS-13<br>Basophils (%): 0.9 %<br>2024-02-14 2:40<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Days Since C1D1: 21","CTMS-13<br>Basophils (%): 0.5 %<br>2024-02-20 9:17<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 27","CTMS-13<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 28","CTMS-13<br>Basophils (%): 0.6 %<br>2024-03-06 9:18<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 42","CTMS-13<br>Basophils (%): 0.5 %<br>2024-03-13 0:35<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Days Since C1D1: 49","CTMS-13<br>Basophils (%): 0.1 %<br>2024-03-20 1:00<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 56","CTMS-13<br>Basophils (%): 0.3 %<br>2024-03-27 9:03<br>Visit: Cycle 4 Day 1<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Days Since C1D1: 63","CTMS-13<br>Visit: Cycle 4 Day 8<br>Eribulin: 1.4 mg/m2, 2.17 mg<br>Evexomostat: 49 mg/m2, 76 mg<br>Days Since C1D1: 70","CTMS-13<br>Basophils (%): 0.6 %<br>2024-04-17 9:20<br>Visit: End of Treatment<br>Days Since C1D1: 84"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","","Both","Both","Er","Ev","Er","Both",""],"line":{"color":"#2222ff","width":2},"marker":{"color":"#2222ff","symbol":"diamond","size":9,"line":{"color":"rgba(214,39,40,1)"}},"error_y":{"color":"rgba(214,39,40,1)"},"error_x":{"color":"rgba(214,39,40,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-20,0,6,14,21,27,27],"y":[1,1,0.40000000000000002,1,1.1000000000000001,1.1000000000000001,1.1000000000000001],"name":"CTMS-14","legendgroup":"CTMS-14","hoverinfo":["text","text","text","text","text","text","text"],"hovertext":["CTMS-14<br>Basophils (%): 1 <br>2024-02-01 0:15<br>Visit: Screening<br>Days Since C1D1: -20","CTMS-14<br>Basophils (%): 1 <br>2024-02-21 9:43<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.1 mg<br>Evexomostat: 49 mg/m2, 74 mg<br>Days Since C1D1: 0","CTMS-14<br>Basophils (%): 0.4 %<br>2024-02-27 9:31<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 6","CTMS-14<br>Basophils (%): 1 %<br>2024-03-06 9:57<br>Visit: Cycle 1 Day 15<br>Days Since C1D1: 14","CTMS-14<br>Basophils (%): 1.1 %<br>2024-03-13 9:22<br>Visit: Cycle 2 Day 1<br>Days Since C1D1: 21","CTMS-14<br>Basophils (%): 1.1 %<br>2024-03-19 9:34<br>Visit: End of Treatment<br>Days Since C1D1: 27","CTMS-14<br>Basophils (%): 1.1 %<br>2024-03-19 9:34<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 27"],"textposition":["top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","","","","",""],"line":{"color":"#22cc22","width":2},"marker":{"color":"#22cc22","symbol":"diamond","size":9,"line":{"color":"rgba(148,103,189,1)"}},"error_y":{"color":"rgba(148,103,189,1)"},"error_x":{"color":"rgba(148,103,189,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-5,0,7],"y":[0.40000000000000002,0.5,0.80000000000000004],"name":"CTMS-15","legendgroup":"CTMS-15","hoverinfo":["text","text","text"],"hovertext":["CTMS-15<br>Basophils (%): 0.4 %<br>2024-03-29 9:11<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-15<br>Basophils (%): 0.5 %<br>2024-04-03 1:24<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 0","CTMS-15<br>Basophils (%): 0.8 %<br>2024-04-10 4:32<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.6 mg<br>Days Since C1D1: 7"],"textposition":["top right","top right","top right"],"text":["","Both","Er"],"line":{"color":"black","width":2},"marker":{"color":"black","symbol":"diamond","size":9,"line":{"color":"rgba(140,86,75,1)"}},"error_y":{"color":"rgba(140,86,75,1)"},"error_x":{"color":"rgba(140,86,75,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-14,0,7,14,21,28,49,56,70],"y":[0.40000000000000002,0.20000000000000001,0,0,0.40000000000000002,0.69999999999999996,0.10000000000000001,0.40000000000000002,0.10000000000000001],"name":"CTMS-16","legendgroup":"CTMS-16","hoverinfo":["text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-16<br>Basophils (%): 0.4 %<br>2024-03-28 2:42<br>Visit: Screening<br>Days Since C1D1: -14","CTMS-16<br>Basophils (%): 0.2 %<br>2024-04-11 2:05<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 0","CTMS-16<br>Basophils (%): 0 %<br>2024-04-18 0:04<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 7","CTMS-16<br>Basophils (%): 0 %<br>2024-04-25 4:41<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 14","CTMS-16<br>Basophils (%): 0.4 %<br>2024-05-02 2:50<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 21","CTMS-16<br>Basophils (%): 0.7 %<br>2024-05-09 9:52<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 100 mg<br>Days Since C1D1: 28","CTMS-16<br>Basophils (%): 0.1 %<br>2024-05-30 0:24<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 49","CTMS-16<br>Basophils (%): 0.4 %<br>2024-06-06 4:29<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 56","CTMS-16<br>Basophils (%): 0.1 %<br>2024-06-20 8:45<br>Visit: End of Treatment<br>Days Since C1D1: 70"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","Both","Er","Er",""],"line":{"color":"#ff7777","width":2},"marker":{"color":"#ff7777","symbol":"diamond","size":9,"line":{"color":"rgba(227,119,194,1)"}},"error_y":{"color":"rgba(227,119,194,1)"},"error_x":{"color":"rgba(227,119,194,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-5,0,6,14,16,22,28,42,49,56],"y":[0.59999999999999998,0.59999999999999998,1,0.5,0.47499999999999998,0.40000000000000002,0.40000000000000002,0.29999999999999999,0.20000000000000001,2],"name":"CTMS-17","legendgroup":"CTMS-17","hoverinfo":["text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-17<br>Basophils (%): 0.6 %<br>2024-05-31 9:33<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-17<br>Basophils (%): 0.6 %<br>2024-06-05 9:56<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.66 mg<br>Evexomostat: 49 mg/m2, 93 mg<br>Days Since C1D1: 0","CTMS-17<br>Basophils (%): 1 %<br>2024-06-11 8:43<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 6","CTMS-17<br>Basophils (%): 0.5 %<br>2024-06-19 9:26<br>Visit: Cycle 1 Day 15<br>Days Since C1D1: 14","CTMS-17<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 93 mg<br>Days Since C1D1: 16","CTMS-17<br>Basophils (%): 0.4 %<br>2024-06-27 9:31<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 2.09 mg<br>Days Since C1D1: 22","CTMS-17<br>Basophils (%): 0.4 %<br>2024-07-03 8:58<br>Visit: Cycle 2 Day 8<br>Evexomostat: 49 mg/m2, 93 mg<br>Days Since C1D1: 28","CTMS-17<br>Basophils (%): 0.3 %<br>2024-07-17 9:06<br>Visit: Cycle 3 Day 1<br>Evexomostat: 49 mg/m2, 93 mg<br>Days Since C1D1: 42","CTMS-17<br>Basophils (%): 0.2 %<br>2024-07-24 9:22<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 1.3 mg<br>Days Since C1D1: 49","CTMS-17<br>Basophils (%): 2 %<br>2024-07-31 9:42<br>Visit: End of Treatment<br>Days Since C1D1: 56"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","","","Ev","Er","Ev","Ev","Er",""],"line":{"color":"#ff00ff","width":2},"marker":{"color":"#ff00ff","symbol":"diamond","size":9,"line":{"color":"rgba(127,127,127,1)"}},"error_y":{"color":"rgba(127,127,127,1)"},"error_x":{"color":"rgba(127,127,127,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-5,0,7,14,22,28,43,49,56,76],"y":[0.59999999999999998,0.5,3.2000000000000002,0.69999999999999996,0.59999999999999998,1.8,0.59999999999999998,1.3,1.8,0.59999999999999998],"name":"CTMS-18","legendgroup":"CTMS-18","hoverinfo":["text","text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-18<br>Basophils (%): 0.6 %<br>2024-06-14 9:43<br>Visit: Screening<br>Days Since C1D1: -5","CTMS-18<br>Basophils (%): 0.5 %<br>2024-06-19 0:34<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.18 mg<br>Evexomostat: 49 mg/m2, 78 mg<br>Days Since C1D1: 0","CTMS-18<br>Basophils (%): 3.2 %<br>2024-06-26 9:28<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 7","CTMS-18<br>Basophils (%): 0.7 %<br>2024-07-03 9:40<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 78 mg<br>Days Since C1D1: 14","CTMS-18<br>Basophils (%): 0.6 %<br>2024-07-11 9:05<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 1.76 mg<br>Days Since C1D1: 22","CTMS-18<br>Basophils (%): 1.8 %<br>2024-07-17 9:38<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 1.76 mg<br>Evexomostat: 49 mg/m2, 8 mg<br>Days Since C1D1: 28","CTMS-18<br>Basophils (%): 0.6 %<br>2024-08-01 9:02<br>Visit: Cycle 3 Day 1<br>Eribulin: 1.1 mg/m2, 1.76 mg<br>Evexomostat: 49 mg/m2, 78 mg<br>Days Since C1D1: 43","CTMS-18<br>Basophils (%): 1.3 %<br>2024-08-07 8:22<br>Visit: Cycle 3 Day 8<br>Eribulin: 1.1 mg/m2, 1.76 mg<br>Days Since C1D1: 49","CTMS-18<br>Basophils (%): 1.8 %<br>2024-08-14 4:57<br>Visit: Cycle 3 Day 15<br>Evexomostat: 49 mg/m2, 78 mg<br>Days Since C1D1: 56","CTMS-18<br>Basophils (%): 0.6 %<br>2024-09-03 0:21<br>Visit: End of Treatment<br>Days Since C1D1: 76"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","","Ev","Er","Both","Both","Er","Ev",""],"line":{"color":"orange","width":2},"marker":{"color":"orange","symbol":"diamond","size":9,"line":{"color":"rgba(188,189,34,1)"}},"error_y":{"color":"rgba(188,189,34,1)"},"error_x":{"color":"rgba(188,189,34,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-14,0,7,21,28,35,49,56],"y":[0,0.59999999999999998,2,0.29999999999999999,0.69999999999999996,0.40000000000000002,0.29999999999999999,0.80000000000000004],"name":"CTMS-19","legendgroup":"CTMS-19","hoverinfo":["text","text","text","text","text","text","text","text"],"hovertext":["CTMS-19<br>Basophils (%): 0 %<br>2024-09-04 8:50<br>Visit: Screening<br>Days Since C1D1: -14","CTMS-19<br>Basophils (%): 0.6 %<br>2024-09-18 9:54<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 0","CTMS-19<br>Basophils (%): 2 %<br>2024-09-25 0:00<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 7","CTMS-19<br>Basophils (%): 0.3 %<br>2024-10-09 0:19<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 21","CTMS-19<br>Basophils (%): 0.7 %<br>2024-10-16 8:22<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Days Since C1D1: 28","CTMS-19<br>Basophils (%): 0.4 %<br>2024-10-23 9:12<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.4 mg/m2, 2.8 mg<br>Evexomostat: 49 mg/m2, 90 mg<br>Days Since C1D1: 35","CTMS-19<br>Basophils (%): 0.3 %<br>2024-11-06 0:24<br>Visit: Cycle 3 Day 1<br>Days Since C1D1: 49","CTMS-19<br>Basophils (%): 0.8 %<br>2024-11-13 0:08<br>Visit: End of Treatment<br>Days Since C1D1: 56"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","Er","Ev","Er","Both","",""],"line":{"color":"#2222ff","width":2},"marker":{"color":"#2222ff","symbol":"star","size":9,"line":{"color":"rgba(23,190,207,1)"}},"error_y":{"color":"rgba(23,190,207,1)"},"error_x":{"color":"rgba(23,190,207,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"lines+markers+text","type":"scatter","x":[-6,0,8,11,18,28,36,37,56],"y":[1.1000000000000001,0.69999999999999996,1.3,1.51,2,1,1,1,1],"name":"CTMS-20","legendgroup":"CTMS-20","hoverinfo":["text","text","text","text","text","text","text","text","text"],"hovertext":["CTMS-20<br>Basophils (%): 1.1 %<br>2024-12-10 0:02<br>Visit: Screening<br>Days Since C1D1: -6","CTMS-20<br>Basophils (%): 0.7 %<br>2024-12-16 4:03<br>Visit: Cycle 1 Day 1<br>Eribulin: 1.4 mg/m2, 3.2 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 0","CTMS-20<br>Basophils (%): 1.3 %<br>2024-12-24 0:38<br>Visit: Cycle 1 Day 8<br>Days Since C1D1: 8","CTMS-20<br>Visit: Cycle 1 Day 8<br>Eribulin: 1.4 mg/m2, 3.2 mg<br>Days Since C1D1: 11","CTMS-20<br>Basophils (%): 2 %<br>2025-01-03 8:45<br>Visit: Cycle 1 Day 15<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 18","CTMS-20<br>Basophils (%): 1 %<br>2025-01-13 8:23<br>Visit: Cycle 2 Day 1<br>Eribulin: 1.1 mg/m2, 2.5 mg<br>Days Since C1D1: 28","CTMS-20<br>Basophils (%): 1 %<br>2025-01-21 6:25<br>Visit: Cycle 2 Day 8<br>Days Since C1D1: 36","CTMS-20<br>Visit: Cycle 2 Day 8<br>Eribulin: 1.1 mg/m2, 2.5 mg<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 37","CTMS-20<br>Basophils (%): 1 %<br>2025-02-10 4:28<br>Visit: Cycle 3 Day 1<br>Evexomostat: 49 mg/m2, 110 mg<br>Days Since C1D1: 56"],"textposition":["top right","top right","top right","top right","top right","top right","top right","top right","top right"],"text":["","Both","","Er","Ev","Er","","Both","Ev"],"line":{"color":"#22cc22","width":2},"marker":{"color":"#22cc22","symbol":"star","size":9,"line":{"color":"rgba(31,119,180,1)"}},"error_y":{"color":"rgba(31,119,180,1)"},"error_x":{"color":"rgba(31,119,180,1)"},"xaxis":"x","yaxis":"y","frame":null},{"connectgaps":true,"mode":"text","type":"scatter","x":[0],"y":[1.5],"text":"High","textposition":"bottom left","showlegend":false,"marker":{"color":"rgba(255,127,14,1)","line":{"color":"rgba(255,127,14,1)"}},"error_y":{"color":"rgba(255,127,14,1)"},"error_x":{"color":"rgba(255,127,14,1)"},"line":{"color":"rgba(255,127,14,1)"},"xaxis":"x","yaxis":"y","frame":null}],"highlight":{"on":"plotly_click","persistent":false,"dynamic":false,"selectize":false,"opacityDim":0.20000000000000001,"selected":{"opacity":1},"debounce":0},"shinyEvents":["plotly_hover","plotly_click","plotly_selected","plotly_relayout","plotly_brushed","plotly_brushing","plotly_clickannotation","plotly_doubleclick","plotly_deselect","plotly_afterplot","plotly_sunburstclick"],"base_url":"https://plot.ly"},"evals":[],"jsHooks":[]}</script><script type="application/htmlwidget-sizing" data-for="htmlwidget-53ec3ab17c40ebfe512e">{"viewer":{"width":"100%","height":400,"padding":0,"fill":true},"browser":{"width":"100%","height":400,"padding":0,"fill":true}}</script>
</body>
</html>
